Hyperlipidaemia, other/unspecified

E4_HYPERLIPNAS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E78.40, E78.42, E78.43, E78.49, E78.5 Hospital discharge: ICD-9 — 2724 Hospital discharge: ICD-8 — 2720[1-9] Cause of death: ICD-10 — E78.40, E78.42, E78.43, E78.49, E78.5 Cause of death: ICD-9 — 2724 Cause of death: ICD-8 — 2720[1-9] 2 out of 7 registries used, show all original rules.	19635
4. Check minimum number of events None	19635
5. Include endpoints None	19635
6. Filter based on genotype QC (FinnGen only)	19024

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	E4_HYPERLIPNAS
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E78[4-5]
HD_ICD_9	2724
HD_ICD_8	2720[1-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E78[4-5]
COD_ICD_9	2724
COD_ICD_8	2720[1-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hyperlipidaemia, other/unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	120574	53798	66469
Only index persons	116174	52282	63892
Unadjusted period prevalence (%)
Whole population	1.71	1.54	1.86
Only index persons	2.21	1.92	2.44
Median age at first event (years)
Whole population	67.74	70.72	65.34
Only index persons	67.71	70.64	65.31

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	19024	8229	10795
Unadjusted period prevalence (%)	4.07	2.92	4.95
Median age at first event (years)	66.63	67.54	65.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
19635: Matched controls
180708

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Single vessel balloon catheter extension

5.1

323.0

724

1359

B01AC24

ATC

ticagrelor; oral

3.7

322.1

1075

2750

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.8

320.4

1734

5958

A10BH01

ATC

sitagliptin; oral

2.5

320.2

2371

9525

B01AA03

ATC

warfarin; systemic

2.0

317.3

4725

25062

ZXD05

NOMESCO Finland

Urgent procedure

1.9

315.4

5897

33712

N02BE01

ATC

paracetamol; systemic, rectal

2.4

310.1

17516

140269

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.3

307.7

3182

9956

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

3.0

307.7

5895

22797

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

14.0

307.7

718

488

C09AA05

ATC

ramipril; oral

2.4

307.7

6773

32335

C10AX09

ATC

ezetimibe; oral

4.9

307.7

5866

14359

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.4

307.7

3629

8908

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.3

307.7

1802

4165

A10AE04

ATC

insulin glargine; parenteral

3.3

307.7

2710

8360

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

6.4

307.7

1560

2388

C03CA01

ATC

furosemide; systemic

2.3

307.7

7750

40455

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

4.8

307.7

1763

3641

I25

ICD-10 Finland

Chronic ischaemic heart disease

4.0

307.7

1600

3933

C10AA03

ATC

pravastatin; oral

3.6

307.7

2298

6366

C07AB07

ATC

bisoprolol; oral

2.8

307.7

12555

69549

R06.0

ICD-10 Finland

Dyspnoea

2.1

307.7

6033

31454

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

5.5

307.7

1602

2884

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.1

307.7

5562

20590

XF402

NOMESCO Finland

ECG with work load test

3.1

307.7

3099

10277

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

4.3

307.7

1156

2576

I20.90

ICD-10 Finland

Angina pectoris, unspecified

4.5

307.7

1207

2580

I25.2

ICD-10 Finland

Old myocardial infarction

4.5

307.7

2464

5572

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.4

307.7

1758

5033

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

307.7

2445

8897

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

6.8

307.7

690

964

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

4.6

307.7

1633

3481

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.8

307.7

1863

4829

E86

ICD-10 Finland

Volume depletion

23.8

307.7

423

167

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

307.7

7312

33140

AN4

Balloon angioplasty and drug eluding stent

5.9

307.7

1295

2140

T90

ICPC

Diabetes non-insulin dependent

2.3

307.7

6036

29344

E78.49

ICD-10 Finland

Other hyperlipidaemia

23.7

307.7

706

284

A10BA02

ATC

metformin; oral

2.4

307.7

7320

35677

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.0

307.7

1754

5634

C10AA04

ATC

fluvastatin; oral

3.4

307.7

2704

8110

I20.00

ICD-10 Finland

Unstable angina

4.8

307.7

1003

1999

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.4

307.7

1802

5291

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

5.4

307.7

2160

4055

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

307.7

4102

20340

AA1

Conventional CABG

5.6

307.7

661

1127

E78.40

ICD-10 Finland

Familial combined hyperlipidaemia

161.7

307.7

243

C10AA05

ATC

atorvastatin; oral

4.6

307.7

13122

55024

103

Kela drug reimbursment

Diabetes, insulin-treated

2.7

307.7

7339

33132

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

307.7

4088

18296

C08CA01

ATC

amlodipine; oral

2.2

307.7

9518

53417

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

4.4

307.7

6898

19633

I10

ICD-10 Finland

Essential (primary) hypertension

4.1

307.7

15884

91849

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

4.5

307.7

1620

3577

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1341.5

307.7

18810

3020

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

2.3

307.7

4852

22352

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.6

307.7

1330

3590

SPAT1262

SPAT

Handing over of treatment supplies

2.3

307.7

4447

20264

A10AE05

ATC

insulin detemir; parenteral

3.9

307.7

1464

3669

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.7

307.7

3432

9704

E87.6

ICD-10 Finland

Hypokalaemia

8.1

307.7

539

631

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

5.4

307.7

3230

6391

Z3231

NOMESCO Finland

Registered nurse

1.9

307.7

5737

32184

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

5.3

307.7

2857

5596

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

5.9

307.7

6349

13482

C10AA07

ATC

rosuvastatin; oral

2.9

307.7

8567

37964

I50.9

ICD-10 Finland

Heart failure, unspecified

2.3

307.7

3633

16112

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

6.8

307.7

669

930

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

23.1

307.7

302

122

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

4.1

307.7

1282

2997

AN1

Coronary angiography

4.8

307.7

4559

10789

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

307.7

10793

63524

E66.01

ICD-10 Finland

Obesity due to excess calories

3.0

307.7

1605

5182

B01AC04

ATC

clopidogrel; oral

5.1

307.7

6682

16528

AA1AD

NOMESCO Finland

CT of head and brain

2.4

307.7

6791

33115

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.6

307.7

6285

27703

AN3

Balloon angioplasty and metallic stent

4.9

307.7

915

1785

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

4.3

307.7

8251

26039

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.9

307.7

2074

4213

A02BC02

ATC

pantoprazole; systemic

1.9

307.7

13677

98811

E66.00

ICD-10 Finland

Metabolic syndrome

3.8

307.7

1445

3683

205

Kela drug reimbursment

Chronic hypertension

2.1

307.7

6866

36308

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

3.8

307.7

2021

5308

A10AC01

ATC

insulin (human); parenteral

3.2

307.7

1887

5832

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

4.8

307.7

1028

2048

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.7

307.7

1952

5262

A10BK03

ATC

empagliflozin; oral

2.6

307.7

2433

9251

I20.01

ICD-10 Finland

Unstable angina

5.1

307.7

1047

1983

C07AB02

ATC

metoprolol; systemic

2.1

307.7

4857

24702

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

27.7

307.7

1535

551

C10AA01

ATC

simvastatin; oral

4.6

307.7

13412

58027

I20.99

ICD-10 Finland

Angina pectoris, unspecified

4.5

307.7

2406

5489

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.8

307.7

6856

28851

E87.5

ICD-10 Finland

Hyperkalaemia

12.4

307.7

380

286

C01DA14

ATC

isosorbide mononitrate; oral

3.9

307.7

5546

16667

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

19.6

307.7

1257

628

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.7

307.7

2413

6659

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

307.7

6299

35894

I25.1

ICD-10 Finland

Atherosclerotic heart disease

4.4

307.7

8293

25977

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.0

307.7

7034

28383

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

18.0

307.7

299

155

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

4.7

307.7

1655

3505

A10AB05

ATC

insulin aspart; parenteral

3.7

307.7

2154

5861

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.3

307.7

3948

17659

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.7

307.7

1148

3013

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

5.9

307.7

830

1345

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.6

307.7

8101

29677

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.6

307.7

2535

7130

Angiography of the heart and coronary arteries

3.8

307.7

2098

5527

I20.09

ICD-10 Finland

Unstable angina

4.5

307.7

2050

4538

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.1

305.1

678

1263

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

301.1

5380

30232

A10AB04

ATC

insulin lispro; parenteral

4.6

287.4

723

1495

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

282.0

4095

21419

R42

ICD-10 Finland

Dizziness and giddiness

1.9

275.2

4827

26837

H04AA01

ATC

glucagon; nasal, parenteral

6.2

274.1

489

740

280

Kela drug reimbursment

Clopidogrel

5.9

273.1

511

811

R4110

NOMESCO Finland

Physiotherapy

1.8

271.6

5493

31896

N18.8

ICD-10 Finland

Other chronic renal failure

4.3

270.6

731

1599

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

270.4

6054

36221

XF404

NOMESCO Finland

Ambulatory ECG

2.4

269.2

2086

8521

A11CC03

ATC

alfacalcidol; systemic

4.9

268.3

613

1169

G47.3

ICD-10 Finland

Sleep apnoea

1.9

267.6

4649

25736

A10AB01

ATC

insulin (human); parenteral

4.1

265.7

780

1817

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.9

265.2

1315

4294

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.4

265.2

2094

8623

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

261.8

3391

16994

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.3

260.7

1047

3018

C03DA01

ATC

spironolactone; oral

2.1

260.2

2720

12583

A10AA01, ,

ATC

4.8

258.8

608

1187

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

4.8

258.1

618

1226

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.8

252.2

801

1975

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.0

251.2

1230

3985

207

Kela drug reimbursment

Chronic arrhythmias

1.9

249.6

3830

20308

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

4.5

247.7

635

1332

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.6

247.7

875

2321

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

245.7

3647

19112

XCK10

NOMESCO Finland

Photography of fundus of eye

2.2

241.7

2210

9670

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.6

241.4

608

1257

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.4

237.6

904

2516

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.4

237.2

1853

7577

A10AE06

ATC

insulin degludec; parenteral

3.8

236.4

776

1957

M04AA01

ATC

allopurinol; systemic

2.0

234.8

3076

15423

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

5.1

234.3

511

935

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

234.0

4345

24409

C10AB05

ATC

fenofibrate; oral

4.9

233.2

533

1016

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

5.8

233.1

441

707

C10AA02

ATC

lovastatin; oral

3.1

228.8

1046

3255

C08CA13

ATC

lercanidipine; oral

1.9

228.7

3235

16640

A10AA02, ,

ATC

3.7

225.0

749

1907

H3600, E103,

ICD-10 Finland

8.9

224.8

291

304

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.4

222.7

594

1285

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.5

222.6

1555

6036

H3603, E103,

ICD-10 Finland

9.2

221.8

280

283

ZXE00

NOMESCO Finland

One hour or less

1.6

221.5

7237

47360

A10BK01

ATC

dapagliflozin; oral

2.4

221.3

1637

6523

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

15.9

221.1

199

116

T89

ICPC

Diabetes insulin dependent

3.6

216.2

769

2047

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

216.1

6963

45332

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

5.4

215.3

446

779

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

3.8

211.5

683

1702

C02AC05

ATC

moxonidine; oral

2.8

211.3

1118

3772

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

7.1

209.8

327

428

Z3226

NOMESCO Finland

Physiotherapist

1.8

208.7

3513

19064

A10BH05

ATC

linagliptin; oral

2.6

207.3

1260

4567

B01AF02

ATC

apixaban; oral

1.9

206.9

2964

15265

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.0

205.8

962

3030

TK800

NOMESCO Finland

Hemodialysis

4.3

205.0

560

1234

R07.3

ICD-10 Finland

Other chest pain

2.1

204.8

2102

9599

M10.9

ICD-10 Finland

Gout, unspecified

2.3

202.2

1653

6875

C10AX13

ATC

evolocumab; parenteral

17.0

201.9

176

R53

ICD-10 Finland

Malaise and fatigue

1.8

200.9

4203

24304

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.1

200.7

441

812

C09AA02

ATC

enalapril; systemic

1.7

200.4

4278

24878

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

5.0

198.3

444

831

A10BJ06

ATC

semaglutide; parenteral

2.9

197.8

1020

3392

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

3.6

196.4

670

1733

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.3

195.3

795

2305

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

8.9

194.5

253

266

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.6

189.5

473

970

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

15.2

189.0

174

106

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.4

187.5

701

1926

A10BB12

ATC

glimepiride; oral

2.3

186.8

1580

6660

I50.0

ICD-10 Finland

Congestive heart failure

2.2

184.6

1717

7526

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

4.3

184.4

492

1064

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

4.7

182.6

439

873

J01DB01

ATC

cefalexin; oral

1.7

182.2

15404

123723

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

4.6

180.0

450

924

C09CA01

ATC

losartan; oral

1.6

178.9

5320

33605

N03AX16

ATC

[U] pregabalin

1.7

178.2

4421

26663

AN2

Balloon angioplasty, including several vessels

3.3

175.2

703

2019

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

4.3

174.3

476

1048

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.2

174.0

1558

6719

L28

ICPC

Limited function/disability (L)

1.7

172.2

3571

20485

N02AX02

ATC

tramadol; systemic, rectal

1.5

172.2

8284

58305

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

171.7

2284

11420

Z2221

NOMESCO Finland

Medical doctor

1.6

171.0

4790

29750

M79.6

ICD-10 Finland

Pain in limb

1.5

170.8

7359

50538

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.9

170.3

527

1273

A12AA04

ATC

calcium carbonate; oral

4.8

169.5

393

758

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

168.9

7483

51669

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

168.2

867

2879

UJF32

NOMESCO Finland

Coloscopy

1.6

167.6

5263

33586

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

8.4

166.7

225

248

R55

ICD-10 Finland

Syncope and collapse

1.9

166.7

2298

11622

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.1

165.6

260

343

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

164.8

5589

36291

E66.8

ICD-10 Finland

Other obesity

2.9

163.6

841

2788

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.1

163.5

360

664

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.2

163.1

673

1966

R4120

NOMESCO Finland

Occupational therapy

2.4

162.9

1261

5107

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

162.5

2213

11140

SPAT1263

SPAT

Sampling

1.5

162.0

7642

53344

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

160.3

6070

40366

C10AB02

ATC

bezafibrate; oral

4.9

159.9

364

691

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

4.0

159.6

467

1083

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.8

159.3

878

3020

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

158.8

1302

5405

Z50.0

ICD-10 Finland

Cardiac rehabilitation

4.8

158.8

369

713

N19

ICD-10 Finland

Unspecified kidney failure

2.9

158.0

807

2665

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

157.5

2260

11569

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4.2

156.8

435

969

WX892

NOMESCO Finland

Monitored bed care

2.2

156.7

1516

6735

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

156.1

1522

6781

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

6.4

155.9

266

384

E78.11

ICD-10 Finland

Other hypertriglyceridemia

12.6

155.5

159

117

I20.91

ICD-10 Finland

Angina pectoris, unspecified

4.7

155.2

371

734

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

155.1

2039

10133

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

155.1

2805

15424

A28

ICPC

Limited function/disability NOS

1.7

154.1

3459

20211

111

Conventional CABG

6.6

152.7

254

357

R51.80

ICD-10 Finland

Headache

1.9

151.6

2343

12275

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

151.5

2794

15445

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

149.7

3311

19253

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.4

149.0

1157

4687

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.8

148.7

283

456

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

148.3

2275

11885

N18.0

ICD-10 Finland

End-stage renal disease

5.3

147.4

305

532

Z94.0

ICD-10 Finland

Kidney transplant status

5.6

147.3

291

486

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

7.9

147.2

210

248

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

9.5

146.9

181

177

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.3

146.6

223

284

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.0

146.2

1801

8744

H36.01

ICD-10 Finland

Diabetic maculopathy

4.9

145.4

336

646

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.6

145.3

285

473

Catheterization and pressure measurement of the left side of the heart

3.9

144.9

448

1081

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

4.5

143.2

365

761

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

143.1

2604

14318

Z71.9

ICD-10 Finland

Counselling, unspecified

2.2

142.6

1262

5402

AA5PD

NOMESCO Finland

CT examination of brain pefusion

5.5

141.9

283

477

B01AB05

ATC

enoxaparin; parenteral

1.5

141.0

6070

41244

A11

ICPC

Chest pain NOS

2.0

139.5

1612

7644

I50.1

ICD-10 Finland

Left ventricular failure

2.3

138.7

1103

4512

B04AB02, ,

ATC

3.7

138.7

466

1192

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

3.1

138.4

602

1814

H3601, E103,

ICD-10 Finland

6.9

137.6

221

299

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

8.6

137.4

182

196

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

136.6

4081

25534

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

136.4

3782

23241

V03AE01

ATC

polystyrene sulfonate; oral

4.8

135.5

319

623

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

134.4

4882

31916

AP1

Catheterization of the left side of the heart

3.9

133.4

416

1010

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.9

133.0

409

983

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

132.5

4685

30430

C08CA02

ATC

felodipine; oral

1.9

132.0

2031

10597

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

131.9

6785

47638

Z01.7

ICD-10 Finland

Laboratory examination

1.8

130.6

2484

13807

C03AA03

ATC

hydrochlorothiazide; oral

1.9

130.5

1904

9765

XF602

NOMESCO Finland

Bloodpressure monitoring

4.7

130.3

315

629

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

129.0

7958

57784

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.0

129.0

1631

7975

R03AC02

ATC

salbutamol; inhalant

1.4

128.7

9249

69078

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

4.6

128.3

318

648

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.5

127.7

324

673

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

127.1

944

3745

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.1

126.0

277

510

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

6.3

125.4

217

318

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

125.2

1202

5310

Coronary artery bypass surgery

3.2

124.6

521

1533

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

6.7

124.1

205

286

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.1

124.0

356

814

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.4

123.9

947

3804

127

Kela drug reimbursment

Transplant complication

4.2

123.9

341

755

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

123.8

12158

95821

E78

ICD-10 Finland

Disorders of lipoprotein metabolism and other lipidaemias

2.7

123.2

687

2374

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

122.9

6287

43939

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

122.8

4558

29838

C07AG02

ATC

carvedilol; oral

2.1

122.7

1249

5643

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.5

122.7

827

3138

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

122.6

2716

15722

K90

ICPC

Stroke/cerebrovascular accident

2.8

122.4

633

2102

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

121.8

6945

49529

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.5

121.6

430

1138

Z50.1

ICD-10 Finland

Other physical therapy

2.2

121.3

1094

4713

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

121.2

2373

13277

A10BJ02

ATC

liraglutide; parenteral

3.0

120.1

542

1668

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.4

120.0

444

1210

ZXA00

NOMESCO Finland

Right side

1.5

119.7

5011

33615

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

119.6

1213

5471

J01MA12

ATC

levofloxacin; systemic

1.6

118.9

3573

22289

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

118.7

2110

11481

A02BC01

ATC

omeprazole; systemic

1.5

118.1

5024

33793

A02BC05

ATC

esomeprazole; systemic

1.4

117.8

7289

52683

WX872

NOMESCO Finland

Intensive care

2.2

117.7

1005

4232

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.8

117.4

375

926

E10

ICD-10 Finland

Type 1 diabetes mellitus

4.2

116.2

320

709

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

6.5

116.1

195

277

M54.5

ICD-10 Finland

Low back pain

1.5

115.7

5826

40482

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

4.1

115.6

334

767

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.1

115.0

503

1520

WZC30

NOMESCO Finland

Teaching

1.6

114.7

2925

17526

Z71.8

ICD-10 Finland

Other specified counselling

1.5

114.6

4748

31732

N06AX11

ATC

mirtazapine; oral

1.5

114.5

5699

39497

ZXA05

NOMESCO Finland

Left side

1.5

114.2

4661

31048

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.0

113.8

1383

6661

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

112.9

2445

14044

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

112.9

3185

19552

C09CA06

ATC

candesartan; oral

1.5

112.7

4232

27695

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.4

112.1

169

213

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.6

111.7

218

360

PA6AD

NOMESCO Finland

CT of neck arteries

2.8

111.3

596

2016

R4180

NOMESCO Finland

Podiatric therapy

4.2

111.1

305

674

J01FF01

ATC

clindamycin; systemic

1.5

111.1

4741

31840

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

110.3

2659

15696

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

3.8

110.1

353

874

J01CA04

ATC

amoxicillin; systemic

1.5

109.9

14268

116878

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

109.6

1487

7430

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

7.0

109.5

173

230

L04AD02

ATC

tacrolimus; systemic

5.4

109.4

221

377

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

109.4

2863

17246

XPX08

NOMESCO Finland

Intraoperative flow measurement

5.1

109.2

238

435

R02

ICPC

Shortness of breath/dyspnoea

1.7

109.2

2341

13401

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.5

109.2

279

583

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.5

109.2

719

2697

I20

ICD-10 Finland

Angina pectoris

3.6

109.0

377

983

A10BD07

ATC

metformin and sitagliptin; systemic

2.3

108.3

905

3775

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.9

107.9

328

782

211

Kela drug reimbursment

Severe hereditary disorders of lipid metabolism (familial hypercholesterolaemia and type III dyslipoproteinemia)

8.5

107.7

144

157

WX402

NOMESCO Finland

General anaesthesia

1.6

107.5

3426

21602

E78.4

ICD-10 Finland

Other hyperlipidaemia

59.1

106.5

C09CA03

ATC

valsartan; oral

1.8

106.4

1861

10061

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

106.3

1010

4437

R60.0

ICD-10 Finland

Localized oedema

1.7

106.2

2319

13334

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.4

104.8

787

3134

160

Kela drug reimbursment

exenatide

3.3

104.5

409

1155

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

5.5

104.5

208

350

E66.9

ICD-10 Finland

Obesity, unspecified

2.8

104.1

549

1842

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.8

103.4

529

1746

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

103.3

4488

30177

XA800

NOMESCO Finland

Neuropsychological investigation

2.5

103.2

691

2611

SPAT1097

SPAT

Recording of ECG

1.6

103.2

2904

17777

A46

ICD-10 Finland

Erysipelas

1.6

102.9

2822

17170

V03AE02

ATC

sevelamer; oral

7.2

102.8

157

201

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.7

102.7

169

235

L04AA06

ATC

mycophenolic acid; systemic

3.4

102.4

379

1033

C08DB01

ATC

diltiazem; oral

2.1

102.4

1086

4975

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

4.8

102.0

239

465

137

Kela drug reimbursment

Uraemia requiring dialysis

5.3

101.9

210

365

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

101.7

2394

14025

OAB50, ,

SPAT

2.1

101.0

1081

4968

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

100.4

1386

6958

B05DA

ATC

Isotonic solutions

6.0

100.3

182

280

ZXA10

NOMESCO Finland

Bilateral

1.5

100.3

3417

21827

R2110

NOMESCO Finland

Giving the first information

2.1

100.1

1040

4727

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

99.9

6665

48422

ZX120

NOMESCO Finland

Intravenous

1.8

99.5

1692

9063

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

99.2

6893

50415

H02AB06

ATC

prednisolone; systemic

1.4

98.8

8532

64671

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.8

98.7

511

1697

WX002

NOMESCO Finland

Sedation and analgesia

1.5

98.5

3510

22627

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

4.3

97.1

260

564

B03XA02

ATC

darbepoetin alfa; parenteral

3.1

97.0

434

1329

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

96.6

4620

31575

FL1AC

NOMESCO Finland

Left cardioangiography

3.3

96.5

387

1110

R11

ICD-10 Finland

Nausea and vomiting

1.9

96.1

1328

6667

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

95.9

2021

11490

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

95.8

5598

39673

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

5.6

95.8

187

309

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

95.6

2831

17507

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.3

94.6

369

1040

C09BA02

ATC

enalapril and diuretics; systemic

1.8

93.8

1654

8947

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

93.7

1338

6787

TFP20

NOMESCO Finland

Cardiodefibrillation

1.8

93.5

1535

8130

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

4.8

93.2

217

420

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

4.5

92.9

232

476

B01AC07

ATC

dipyridamole; systemic

2.2

92.4

875

3836

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

2.6

92.4

577

2109

SPAT1254

SPAT

Administration of medicine

1.6

91.9

2615

16012

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

4.6

91.9

223

447

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.7

91.8

297

740

B05DB

ATC

Hypertonic solutions

6.1

91.6

165

252

E83.50

ICD-10 Finland

Hypercalcemia

5.7

91.4

176

287

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.1

91.4

930

4191

Z49.2

ICD-10 Finland

Other dialysis

5.7

91.3

174

281

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.1

91.2

163

247

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

91.2

3123

19928

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.4

90.9

670

2645

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

90.8

5282

37330

A98

ICPC

Health maint/preventive medicine

1.7

90.7

18066

157144

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

90.4

3434

22390

H3601, E113,

ICD-10 Finland

3.4

90.1

332

903

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

90.0

2994

18978

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

7.8

89.8

128

151

I50

ICD-10 Finland

Heart failure

2.4

89.8

672

2670

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.1

89.8

902

4045

J01MA02

ATC

ciprofloxacin; systemic

1.4

89.1

7124

53047

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

7.2

89.1

136

174

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.6

89.0

174

288

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

88.6

1807

10172

E78.2

ICD-10 Finland

Mixed hyperlipidaemia

12.6

88.2

K76

ICPC

Ischaemic heart dis without angina

2.6

88.2

536

1933

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.3

88.1

688

2785

L17

ICPC

Foot/toe symptom/complaint

1.4

87.6

4837

33833

M10

ICD-10 Finland

Gout

2.1

86.9

919

4200

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

5.2

86.7

185

332

H03AA01

ATC

levothyroxine sodium; systemic

1.5

86.5

3643

24220

N05CF01

ATC

zopiclone; oral

1.4

85.7

5737

41445

E78.10

ICD-10 Finland

Familial hypertriglyceridemia

28.2

85.2

3025

Kela drug reimbursment

Calcium carbonate

6.8

84.7

137

187

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

84.7

754

3224

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.7

84.6

273

679

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

84.6

2801

17715

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

3.8

84.5

262

634

S18

ICPC

Laceration/cut

1.3

84.1

8366

64251

C10AB04

ATC

gemfibrozil; oral

4.4

84.0

215

450

G45.3

ICD-10 Finland

Amaurosis fugax

2.9

83.9

415

1345

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

83.8

5508

39634

196

Kela drug reimbursment

Paricalcitol and cinacalcet

7.1

83.7

129

167

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

5.4

83.4

168

286

UKC02

NOMESCO Finland

Cystoscopy

1.5

83.2

3190

20795

H3603, E113,

ICD-10 Finland

4.5

83.1

211

439

S97

ICPC

Chronic ulcer skin

1.9

83.1

1157

5816

A10AD05

ATC

insulin aspart; parenteral

3.0

83.0

383

1194

A10BH02

ATC

vildagliptin; oral

2.8

82.9

432

1440

SPAT1301

SPAT

No procedures

1.4

82.8

5605

40512

PD4HE

NOMESCO Finland

Postoperative lower extremity artery ultrasound examination with Doppler method

10.1

82.4

Multi-vessel balloon catheter extension

5.5

82.2

165

280

A10AB06

ATC

insulin glulisine; parenteral

4.3

82.2

220

477

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.2

82.1

224

493

SPAT1236

SPAT

Informing family of child’s disability

2.8

81.9

429

1434

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.7

81.8

193

378

N30.0

ICD-10 Finland

Acute cystitis

1.6

81.7

2464

15257

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

3.4

81.2

307

849

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

80.9

1162

5898

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

80.6

2064

12301

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4.1

80.4

227

513

C01BD01

ATC

amiodarone; systemic

2.3

80.3

616

2474

CKC15

NOMESCO Finland

Panretinal photocoagulation

4.4

80.2

205

429

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

3.4

79.9

294

799

Z2446

NOMESCO Finland

Social worker

2.0

79.8

979

4716

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

79.6

2766

17656

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

79.3

1118

5640

I20.88

ICD-10 Finland

Other angina pectoris other occlusion in coronary artery

7.8

79.3

114

136

PE1AT

NOMESCO Finland

Femoral artery PTA

3.5

79.2

277

728

SPAT1312

SPAT

General health counselling

1.4

78.6

5266

37927

WX722

NOMESCO Finland

PEEP

2.0

78.3

882

4124

M48.0

ICD-10 Finland

Spinal stenosis

1.5

78.1

2397

14889

A10BX01

ATC

guar gum; oral

2.2

77.9

708

3052

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

77.9

8351

64590

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

77.7

1082

5436

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.9

77.7

1019

5021

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

9.7

77.5

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

77.4

1788

10380

C09DA01

ATC

losartan and diuretics; oral

1.6

76.5

2016

12088

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.6

76.5

264

688

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

76.3

5994

44228

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

4.4

76.2

197

416

Z2445

NOMESCO Finland

Psychologist

2.5

76.0

492

1829

E83.51

ICD-10 Finland

Hypocalcemia

15.5

75.8

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

4.0

75.7

218

500

XF640, ,

NOMESCO Finland

2.4

75.6

551

2164

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

75.3

1516

8489

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

75.2

2708

17393

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

75.2

1507

8428

315

Kela drug reimbursment

Clopidogrel

3.7

75.2

241

597

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.1

75.1

318

943

I20.9

ICD-10 Finland

Angina pectoris, unspecified

3.3

74.8

292

824

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

74.7

1964

11765

M25.5

ICD-10 Finland

Pain in joint

1.4

74.2

4813

34421

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

74.1

2189

13471

PEN23

NOMESCO Finland

Plastic repair of femoral artery

4.1

74.1

213

488

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

73.9

6233

46432

WW200

NOMESCO Finland

Immunization

2.5

73.8

470

1734

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

7.1

73.8

114

148

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

73.5

1687

9774

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

73.4

8968

70431

H3600, E113,

ICD-10 Finland

3.4

73.4

273

747

Z51.88

ICD-10 Finland

Other specified medical care

2.7

73.4

413

1433

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.9

73.3

354

1132

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.0

73.3

815

3792

R04.0

ICD-10 Finland

Epistaxis

1.7

73.0

1411

7812

G44.2

ICD-10 Finland

Tension-type headache

1.6

73.0

1900

11353

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

7.5

72.7

108

134

A02BC03

ATC

lansoprazole; oral

1.4

72.7

5034

36361

P01AB01

ATC

metronidazole; oral, rectal

1.3

72.6

6256

46727

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

72.5

1210

6426

ZXD00

NOMESCO Finland

Emergency procedure

2.3

72.4

545

2170

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.9

72.4

350

1120

N03AX12

ATC

[U] gabapentin; oral

1.5

72.2

2667

17209

SPAT1310

SPAT

Counselling related to known health issue

1.4

72.1

5385

39347

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

71.9

11590

94446

M10.0

ICD-10 Finland

Idiopathic gout

2.1

71.7

684

3005

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

71.4

1536

8748

N17

ICPC

Vertigo/dizziness

1.6

71.3

2047

12507

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.7

71.3

395

1360

I49.5

ICD-10 Finland

Sick sinus syndrome

2.0

71.0

778

3599

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

70.9

2933

19346

A10AD01

ATC

insulin (human); parenteral

3.0

70.8

319

981

NHQ40

NOMESCO Finland

Amputation of toe

2.9

70.8

352

1144

ANE

Coronary internal ultrasound (IVUS)

7.6

70.6

103

125

A04

ICPC

Weakness/tiredness general

1.5

70.6

2244

14023

EBA00

NOMESCO Finland

Extraction of tooth

1.3

70.5

5639

41608

C09CA07

ATC

telmisartan; oral

1.7

70.4

1361

7534

Z01.3

ICD-10 Finland

Examination of blood pressure

3.2

69.9

291

854

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

69.8

1391

7762

V03AE03

ATC

lanthanum carbonate; oral

7.3

69.8

106

135

R07.2

ICD-10 Finland

Precordial pain

2.6

69.5

412

1468

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.5

69.1

137

230

R52.9

ICD-10 Finland

Pain, unspecified

1.7

69.1

1546

8893

Z00.8

ICD-10 Finland

Other general examinations

1.7

69.0

1235

6689

G04CA02

ATC

tamsulosin; oral

1.4

69.0

4961

35988

R5110, ,

SPAT

1.8

68.9

1145

6070

N06AX21

ATC

duloxetine; oral

1.6

68.7

1678

9866

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.0

68.4

124

191

A02BA02

ATC

ranitidine; systemic

1.4

68.3

3386

23082

I63

ICD-10 Finland

Cerebral infarction

4.0

68.0

196

450

SPAT1260

SPAT

Consultation of another employee

1.4

68.0

3049

20407

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.4

68.0

482

1869

J01AA02

ATC

doxycycline; systemic

1.3

67.9

13991

117464

C09AA04

ATC

perindopril; oral

1.9

67.8

983

4999

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

10.8

67.7

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

4.5

67.6

171

355

R31

ICD-10 Finland

Unspecified haematuria

1.6

67.6

1964

12026

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.7

67.6

159

311

A10BX07

ATC

[U] liraglutide

3.4

67.4

250

683

ZY010

NOMESCO Finland

Hospital outpatient

2.1

67.3

639

2801

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

67.2

2920

19423

N25.0

ICD-10 Finland

Renal osteodystrophy

8.3

67.1

101

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

67.1

2137

13352

C08CA05

ATC

nifedipine; systemic

1.8

67.0

1109

5871

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.3

66.8

139

244

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

66.6

1606

9408

A10BG03

ATC

pioglitazone; oral

2.4

66.6

482

1886

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

4.0

66.6

194

449

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.4

66.6

468

1808

SPAT1054

SPAT

Examination of peripheral nervous system

2.7

66.3

359

1221

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.4

66.3

466

1800

H05BX01

ATC

cinacalcet; oral

5.2

66.2

141

253

N05BA04

ATC

oxazepam; oral

1.4

66.2

4044

28553

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.9

65.9

819

3959

E66.0

ICD-10 Finland

Obesity due to excess calories

3.7

65.8

215

540

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

65.3

7486

57964

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

65.1

1587

9320

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

64.8

2695

17766

R50.9

ICD-10 Finland

Fever, unspecified

1.5

64.8

2367

15212

CKC12

NOMESCO Finland

Photocoagulation of retina

2.0

64.4

761

3615

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

64.4

1232

6795

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

64.2

2279

14558

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

64.0

1325

7466

A10BJ05

ATC

dulaglutide; parenteral

2.7

63.7

343

1164

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

63.5

1020

5351

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.9

63.2

297

936

I47.2

ICD-10 Finland

Ventricular tachycardia

2.5

62.8

407

1514

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.8

62.8

1021

5375

TK810

NOMESCO Finland

Hemofiltration

4.9

62.5

141

266

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

3.3

62.5

237

657

K28

ICPC

Limited function/disability (K)

2.4

62.3

445

1731

I20.0

ICD-10 Finland

Unstable angina

3.8

62.3

193

467

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

62.2

4286

30802

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.8

61.6

945

4888

B04AB01, ,

ATC

3.2

61.4

248

715

B01AB10

ATC

tinzaparin; parenteral

1.6

61.4

1661

9995

H25.8

ICD-10 Finland

Other senile cataract

1.5

61.1

2177

13908

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

2.7

61.1

342

1184

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

4.7

61.0

143

279

T82

ICPC

Obesity

2.2

60.7

515

2158

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.1

60.7

634

2882

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

60.5

3196

21978

K91

ICPC

Cerebrovascular disease

3.0

60.4

274

846

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.3

60.3

469

1895

H26.4

ICD-10 Finland

After-cataract

1.5

60.1

1926

12032

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

5.6

60.1

116

190

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

60.1

1730

10557

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

59.8

1738

10628

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.4

59.7

422

1635

R05

ICD-10 Finland

Cough

1.4

59.6

3380

23515

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

59.3

820

4106

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

59.2

698

3313

L03

ICPC

Low back symptom/complaint

1.4

59.2

4185

30158

SPAT1325

SPAT

Vaccination

1.3

59.1

6005

45573

J01FA06

ATC

roxithromycin; oral

1.3

58.9

6475

49653

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

58.8

1127

6215

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

58.8

1575

9453

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

58.7

446

1784

K30

ICD-10 Finland

Functional dyspepsia

1.6

58.6

1668

10151

R4130

NOMESCO Finland

Speech therapy

2.4

58.2

416

1619

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.7

58.1

330

1151

K02.1

ICD-10 Finland

Caries of dentine

1.3

57.8

8990

71982

N06AB04

ATC

citalopram; systemic

1.4

57.8

3179

21993

K74

ICPC

Ischaemic heart dis with angina

3.0

57.8

257

785

E87.2

ICD-10 Finland

Acidosis

100.1

57.7

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

57.5

976

5201

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.6

57.4

1646

10029

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.7

57.4

317

1090

K92.1

ICD-10 Finland

Melaena

1.8

57.4

950

5026

B01AC06

ATC

acetylsalicylic acid; oral

2.1

57.3

570

2544

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

3.5

56.9

205

550

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

22.5

56.8

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

4.4

56.6

147

312

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

56.5

11063

90989

TK820

NOMESCO Finland

Peritoneal dialysis

5.8

56.5

106

169

XKD00

NOMESCO Finland

Uroflowmetry

1.4

56.3

3229

22483

WX723

NOMESCO Finland

CPAP therapy

2.0

56.3

665

3159

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

56.1

678

3245

N02AA05

ATC

oxycodone; systemic

1.4

56.0

3171

22029

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

3.1

55.9

234

690

SFA10

NOMESCO Finland

One-surface restoration

1.3

55.5

8519

67976

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.7

55.4

180

451

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.2

55.3

473

1989

SPAT1053

SPAT

Memory test

1.4

55.3

2916

20016

A06AD11

ATC

lactulose; oral

1.4

55.0

2544

17064

P20

ICPC

Memory disturbance

1.4

54.7

2579

17357

GD1LA

NOMESCO Finland

2.8

54.6

291

982

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

54.6

761

3820

AA2

Off pump CABG sternotomy

5.0

54.1

119

220

J01DA01

ATC

[U] cefalexin

1.3

54.1

10324

84441

A12BA01

ATC

potassium chloride; oral

1.9

54.0

744

3719

A10BX04

ATC

[U] exenatide

3.4

53.9

198

538

N06AX16

ATC

venlafaxine; oral

1.5

53.9

1763

11050

Z26.9

ICD-10 Finland

Need for immunization against unspecified infectious disease

2.8

53.9

270

882

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

53.9

356

1337

M03BX02

ATC

tizanidine; oral

1.3

53.7

9969

81241

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

7.4

53.6

100

171

Kela drug reimbursment

Degludekinsuliini

9.2

53.5

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

53.5

1910

12188

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

53.4

10174

83134

162

Kela drug reimbursment

liraglutide

3.3

53.3

209

592

SPAT1285

SPAT

Provision of consultation response

1.8

53.2

888

4707

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

53.0

2036

13180

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.3

52.9

395

1568

R00.2

ICD-10 Finland

Palpitations

1.7

52.8

1066

5958

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

52.7

1891

12077

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.3

52.6

432

1787

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

52.5

2933

20311

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

2.6

52.2

301

1058

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.5

52.1

334

1237

C07AB08

ATC

celiprolol; oral

2.1

52.0

491

2148

XCK00

NOMESCO Finland

Perimetry

1.7

51.5

1117

6360

XCW10

NOMESCO Finland

Assessment of vision

2.7

51.5

289

1002

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

51.4

1446

8764

R03BB04

ATC

tiotropium bromide; inhalant

1.5

51.4

1809

11506

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

5.7

51.3

159

N18

ICPC

Paralysis/weakness

2.4

51.3

360

1390

RD210, ,

NOMESCO Finland

2.9

51.1

252

816

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

51.0

1233

7212

FXZ00

NOMESCO Finland

Off-pump cardiac operation

4.1

50.8

142

319

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.1

50.8

212

624

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.1

50.8

213

629

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.1

50.6

506

2263

PD5AD

NOMESCO Finland

CT of aorta

2.3

50.4

397

1613

E78.8

ICD-10 Finland

Other disorders of lipoprotein metabolism

12.7

50.2

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

50.2

737

3759

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

49.9

6332

49175

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

49.9

1877

12094

M79.1

ICD-10 Finland

Myalgia

1.5

49.6

1968

12810

SPAT1216

SPAT

Assessment of functional ability

1.4

49.4

2771

19185

E66

ICD-10 Finland

Obesity

1.9

49.3

600

2878

B04AC02, ,

ATC

4.9

49.3

112

213

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

49.3

1798

11515

OAB72

NOMESCO Finland

Weight control and weight loss guidance

4.8

49.0

112

214

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

3.8

49.0

153

373

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

48.9

1246

7380

R4135

NOMESCO Finland

Rehabilitation for hearing problems

2.3

48.9

388

1582

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

48.6

3450

24774

C07AB03

ATC

atenolol; systemic

1.7

48.5

1030

5833

2724A

ICD-9 Finland

Disorders of lipoid metabolism, Other and unspecified hyperlipidaemia[DYSLIPOPROTEINAEMIA]

+∞

48.4

2724X

ICD-9 Finland

Disorders of lipoid metabolism, Other and unspecified hyperlipidaemia[HYPERLIPOIDAEMIA ALIA]

+∞

48.4

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

2.6

48.4

295

1066

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

48.3

4275

31669

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

48.3

2365

15997

C10BA06

ATC

rosuvastatin and ezetimibe; oral

2.7

48.3

259

878

K78

ICPC

Atrial fibrillation/flutter

1.5

47.8

1459

8999

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

47.7

1082

6230

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

47.7

7129

56369

A10BX02

ATC

repaglinide; oral

2.8

47.7

245

812

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

47.6

883

4821

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.5

47.6

302

1113

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

47.6

1630

10302

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.5

47.5

1626

10275

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

47.2

2658

18399

N05AH04

ATC

quetiapine; oral

1.4

47.2

2277

15355

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

2.8

47.0

243

808

C09DA06

ATC

candesartan and diuretics; oral

1.6

46.9

1289

7767

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

46.5

1593

10068

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.7

46.4

248

839

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

46.4

1526

9564

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.1

46.3

196

582

Z72.0

ICD-10 Finland

Tobacco use

2.3

46.2

369

1508

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

2.2

46.2

418

1799

J20

ICD-10 Finland

Acute bronchitis

1.5

45.9

1501

9392

A10BB01

ATC

glibenclamide; oral

1.8

45.9

679

3471

FN1LE

NOMESCO Finland

Mesurement of coronary artery reserve with iv vasodilatator

10.9

45.8

SPAT1255

SPAT

Intravenous administration of medicine

1.6

45.8

1131

6647

C09DA07

ATC

telmisartan and diuretics; oral

1.8

45.8

721

3757

C09DX04

ATC

valsartan and sacubitril; oral

3.1

45.7

199

601

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

45.6

551

2637

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

45.6

6053

47135

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.4

45.5

BEF00, ,

SPAT

4.2

45.5

122

266

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.0

45.4

126

B01AC22

ATC

prasugrel; oral

5.0

45.3

182

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

3.6

45.3

153

394

SFA20

NOMESCO Finland

Two-surface restoration

1.2

45.3

8931

72689

N06AA09

ATC

amitriptyline; systemic

1.5

45.1

1513

9519

K89

ICPC

Transient cerebral ischaemia

3.1

45.0

188

554

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

44.7

7305

58212

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

3.5

44.6

158

420

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

44.4

224

735

ACC51

NOMESCO Finland

Release of median nerve

1.6

44.4

1104

6499

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

44.3

611

3055

R05

ICPC

Cough

1.3

44.2

3571

26079

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

2.5

44.2

282

1043

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

7.0

44.1

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.0

44.1

493

2297

296

Kela drug reimbursment

Rivaroxaban for the treatment of coronary heart disease

12.6

44.0

I20.19

ICD-10 Finland

Angina angiospastic

5.3

44.0

156

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

43.9

590

2925

SPAT1153

SPAT

Removal of sutures

1.3

43.9

5637

43675

K84

ICPC

Heart disease other

2.0

43.8

483

2239

I20.10

ICD-10 Finland

Angina angiospastic

4.6

43.7

107

217

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.7

43.6

241

830

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

43.6

2970

21157

C10AC02

ATC

colestipol; oral

6.0

43.5

122

N19

ICPC

Speech disorder

2.7

43.5

231

779

C09AA03

ATC

lisinopril; oral

1.7

43.4

809

4423

C02EA02, ,

ATC

1.7

43.4

765

4118

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.5

43.4

276

1019

M02AA07

ATC

piroxicam; topical

1.3

43.4

6202

48641

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

3.9

43.2

132

317

C08CA07

ATC

nisoldipine; oral

2.8

43.2

223

741

WX780

NOMESCO Finland

Remote monitoring CPAP

1.8

43.1

654

3370

C03BA11

ATC

indapamide; oral

2.0

43.0

496

2337

R13

ICD-10 Finland

Dysphagia

1.6

43.0

1111

6599

R1260

NOMESCO Finland

Evaluation of communicative skills

2.4

42.8

289

1097

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

6.5

42.7

103

N06AB10

ATC

escitalopram; oral

1.4

42.7

2466

17119

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.0

42.5

476

2219

SPAT1139

SPAT

Nutrition survey

1.9

42.4

531

2573

H53.4

ICD-10 Finland

Visual field defects

2.2

42.4

356

1487

PEF24

NOMESCO Finland

Thrombendarterectomy of deep femoral artery

4.4

42.2

107

223

S06.0

ICD-10 Finland

Concussion

1.5

42.2

1531

9781

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

42.1

2002

13448

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

42.0

2174

14817

N17.8

ICD-10 Finland

Other acute renal failure

2.9

42.0

200

636

I63.8

ICD-10 Finland

Other cerebral infarction

3.2

41.9

172

502

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

2.7

41.8

232

801

WVA20

NOMESCO Finland

Medicine administration

2.1

41.7

411

1829

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.9

41.7

566

2817

S29

ICPC

Skin symptom/complaint other

1.3

41.6

3023

21722

H53.2

ICD-10 Finland

Diplopia

1.9

41.6

504

2415

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

41.6

961

5556

E78.21

ICD-10 Finland

Remnant hyperlipidemia

202.9

41.5

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.0

41.4

182

553

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.9

41.4

534

2613

2720X

ICD-9 Finland

Disorders of lipoid metabolism, Pure hypercholesterolaemia[HYPERCHOLESTEROLAEMIA ALIA]

+∞

41.4

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

41.4

837

4678

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

41.1

1607

10414

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

41.1

4073

30525

EB1AA, ,

SPAT

1.7

41.1

825

4602

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

41.0

924

5308

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.7

41.0

869

4916

SPAT1104

SPAT

Monitoring of emergency patient

1.6

41.0

1077

6421

N30

ICD-10 Finland

Cystitis

1.6

40.9

1003

5882

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

40.9

942

5441

I15.0

ICD-10 Finland

Renovascular hypertension

4.7

40.9

188

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

6.5

40.9

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.4

40.8

1744

11492

SPAT1229

SPAT

Assessment of need for aid

1.5

40.8

1317

8214

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

4.1

40.7

113

253

N18

ICD-10 Finland

Chronic kidney disease

2.8

40.7

208

688

I20.8

ICD-10 Finland

Other forms of angina pectoris

3.2

40.6

161

460

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

3.5

40.5

141

371

Z01.2

ICD-10 Finland

Dental examination

1.2

40.4

6588

52318

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

40.3

787

4356

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.6

40.3

231

811

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

5.3

40.3

145

C07FB02

ATC

metoprolol and felodipine; systemic

1.9

40.2

504

2444

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

40.0

882

5040

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

40.0

1109

6693

K77

ICPC

Heart failure

2.1

40.0

389

1723

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

39.9

461

2173

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

39.9

3980

29839

C01AA05

ATC

digoxin; systemic

1.5

39.8

1399

8876

250, ,

Kela drug reimbursment

2.5

39.8

265

1000

I20.08

ICD-10 Finland

Unstable angina

6.7

39.8

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

4.5

39.7

204

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

39.6

6156

48601

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

8.1

39.6

SPAT1098

SPAT

Exercise ECG

2.1

39.5

378

1663

C10AX14

ATC

alirocumab; parenteral

14.0

39.5

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

39.5

2172

14946

CL2S4, ,

SPAT

2.7

39.5

212

720

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

3.6

39.4

131

334

A10BJ01

ATC

exenatide; parenteral

3.0

39.2

179

556

R10.0

ICD-10 Finland

Acute abdomen

2.0

39.2

459

2174

WX110, ,

SPAT

1.7

39.2

699

3775

B04AC04, ,

ATC

3.8

39.1

123

302

K08.3

ICD-10 Finland

Retained dental root

1.5

39.0

1228

7617

R33

ICD-10 Finland

Retention of urine

1.5

39.0

1402

8937

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

39.0

952

5578

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.9

38.8

475

2284

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

38.8

1158

7101

WZC00, ,

SPAT

1.5

38.8

1409

9000

M01AB05

ATC

diclofenac; systemic, rectal

1.2

38.7

11158

93772

J01CF05

ATC

flucloxacillin; systemic

1.6

38.7

862

4937

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

3.8

38.6

119

288

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

38.5

1604

10515

2504B

ICD-9 Finland

Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]

6.1

38.2

103

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.2

38.1

156

455

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

38.1

1588

10413

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

38.0

531

2666

B01AE07

ATC

dabigatran etexilate; oral

1.7

38.0

700

3814

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.1

38.0

158

465

A10BG02

ATC

rosiglitazone; oral

2.5

37.8

253

957

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

37.6

837

4792

I44.1

ICD-10 Finland

Atrioventricular block, second degree

2.1

37.6

386

1744

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

4.9

37.5

158

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

3.4

37.4

137

373

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

37.1

429

2023

WX290

NOMESCO Finland

Other blockage of nerve

1.2

37.1

6179

49066

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

3.5

36.9

128

336

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

36.9

1225

7682

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

36.8

688

3764

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.1

36.8

160

484

N02BF02

ATC

pregabalin; oral

1.6

36.7

802

4572

R41.3

ICD-10 Finland

Other amnesia

1.9

36.7

503

2512

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

4.9

36.6

158

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.3

36.5

276

1103

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

4.6

36.5

180

K07

ICPC

Swollen ankles/oedema

1.7

36.5

769

4343

OAB43, ,

SPAT

0.7

36.5

1226

16161

SFA30

NOMESCO Finland

Three-surface restoration

1.2

36.1

6595

52827

D11

ICPC

Diarrhoea

1.5

35.9

1349

8667

PEF25

NOMESCO Finland

Thrombendarterectomy of superficial femoral artery

3.9

35.9

109

261

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

35.8

232

865

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

3.5

35.8

123

321

N02BF01

ATC

gabapentin; oral

1.5

35.7

1148

7150

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

8.0

35.7

Z96.4

ICD-10 Finland

Presence of endocrine implants

11.2

35.6

K29

ICPC

Cardiovascular sympt/complt other

1.7

35.6

743

4186

I95.9

ICD-10 Finland

Hypotension, unspecified

2.4

35.6

247

951

C09DA03

ATC

valsartan and diuretics; oral

1.6

35.5

800

4594

G63.2

ICD-10 Finland

Diabetic polyneuropathy

4.1

35.4

100

227

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

35.4

4338

33263

M54

ICD-10 Finland

Dorsalgia

1.4

35.4

1580

10482

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

35.4

965

5798

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

4.5

35.4

181

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

35.2

830

4819

I65.3

ICD-10 Finland

Occlusion and stenosis of multiple and bilateral precerebral arteries

6.2

35.2

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.3

35.2

278

1133

K02

ICPC

Pressure/tightness of heart

2.0

35.1

372

1701

U02

ICPC

Urinary frequency/urgency

1.4

35.0

2041

14158

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.6

35.0

747

4232

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

35.0

1214

7680

R41.0

ICD-10 Finland

Disorientation, unspecified

1.9

34.9

488

2452

E0000UV, ,

ATC

1.2

34.9

6350

50799

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

34.9

517

2645

R03BA05

ATC

fluticasone; inhalant

1.3

34.9

2549

18293

AB2

AVR bio, stent

3.2

34.8

141

409

J01CA08

ATC

pivmecillinam; oral

1.2

34.7

5289

41533

3013

Kela drug reimbursment

Rivaroxaban for the treatment of coronary artery disease

8.0

34.6

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

34.6

984

5970

3AC01, ,

NOMESCO Finland

3.0

34.5

159

497

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.5

34.5

1026

6283

J01EA01

ATC

trimethoprim; systemic

1.3

34.5

3789

28674

R47.0

ICD-10 Finland

Dysphasia and aphasia

2.8

34.3

173

569

AS4

Physiological pacemaker insertion DDD (R)

2.3

34.2

253

1002

WZC30, ,

SPAT

1.6

34.2

854

5029

CLA10, ,

SPAT

5.9

34.2

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

2.1

34.1

315

1368

A10BD20

ATC

metformin and empagliflozin; oral

2.4

34.0

230

875

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

3.6

33.9

113

289

FN2EA

NOMESCO Finland

Coronary rotablation

4.1

33.8

207

C07BB07

ATC

bisoprolol and thiazides; systemic

1.7

33.8

628

3430

B23.8

ICD-10 Finland

HIV disease resulting in other specified conditions

9.0

33.8

SPAT1211

SPAT

Application of soft bandage

1.4

33.6

1353

8805

S22.3

ICD-10 Finland

Fracture of rib

1.5

33.6

1114

6979

U13

ICPC

Bladder symptom/complaint other

1.9

33.6

434

2125

R01AD09

ATC

mometasone; nasal

1.2

33.5

6511

52368

PEN24

NOMESCO Finland

Plastic repair of deep femoral artery

4.5

33.5

174

K01

ICPC

Heart pain

2.4

33.5

227

865

XPX00

NOMESCO Finland

Intraoperative angiography

4.0

33.4

229

M10.3

ICD-10 Finland

Gout due to impairment of renal function

4.1

33.4

213

XG466

NOMESCO Finland

Sleep oxymetry

1.8

33.4

482

2447

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

3.4

33.3

122

332

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

3.2

33.3

134

387

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

33.3

607

3299

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

33.3

536

2812

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

3.3

33.3

125

346

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

33.2

6307

50601

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

33.2

3541

26682

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.7

33.1

616

3365

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

33.0

546

2887

KMAK, ,

NOMESCO Finland

1.2

32.9

7446

60745

388

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of familial hypercholesterolaemia

311.2

32.8

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.6

32.8

864

5151

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

2.0

32.8

367

1713

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

3.5

32.7

113

296

A01

ICPC

Pain general/multiple sites

1.4

32.7

1308

8502

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

32.7

1484

9870

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

5.1

32.6

127

104

Kela drug reimbursment

Thyroid insufficiency

1.5

32.6

951

5799

ZPB96

NOMESCO Finland

Other material in vessel transplant

6.0

32.6

FP3A5

NOMESCO Finland

ECG with work load test

4.0

32.6

213

L60.0

ICD-10 Finland

Ingrowing nail

1.7

32.5

644

3580

UDC00

NOMESCO Finland

Ear microscopy

1.5

32.5

1164

7409

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

32.4

3226

24094

RJ410, ,

NOMESCO Finland

4.6

32.4

160

K59.0

ICD-10 Finland

Constipation

1.6

32.4

848

5048

XCH00

NOMESCO Finland

Eye pressure measurement

1.6

32.3

793

4649

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.9

32.3

411

2004

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

32.2

1090

6859

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.7

32.2

636

3533

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

4.9

32.1

136

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

32.0

2872

21167

SPAT1281

SPAT

Other administrative function

1.5

32.0

1159

7392

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

31.9

2113

14933

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

1.8

31.9

524

2765

L04AD01

ATC

ciclosporin; systemic

2.3

31.9

258

1063

I44.0

ICD-10 Finland

Atrioventricular block, first degree

2.3

31.8

257

1058

H02AB04

ATC

methylprednisolone; systemic

1.3

31.7

2167

15384

N06AB06

ATC

sertraline; oral

1.4

31.7

1315

8607

H02AB09

ATC

hydrocortisone; systemic

2.2

31.6

279

1191

WX320

NOMESCO Finland

Spinalanesthesy

1.3

31.6

3922

30061

G04BD12

ATC

mirabegron; oral

1.3

31.6

2043

14390

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

31.4

871

5252

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

31.4

467

2393

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

3.6

31.4

103

261

K92

ICPC

Atherosclerosis/periph vascular dis

2.3

31.3

234

932

I70.1

ICD-10 Finland

Atherosclerosis of renal artery

4.4

31.2

165

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

31.1

774

4552

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.6

31.1

719

4155

ANB

Coronary thrombectomy

4.9

31.1

129

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

31.0

1989

13990

FN2CD

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of vein graft

7.0

30.9

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

4.0

30.8

206

N01

ICPC

Headache

1.5

30.7

1062

6711

PA6AM

NOMESCO Finland

Simple MRI examination of neck vasculature with 3 Tesla magnet

7.1

30.5

D07AC01

ATC

betamethasone; topical

1.2

30.4

5745

45971

PWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system

3.9

30.4

216

SPAT1059

SPAT

Spirometry at the office

1.6

30.4

782

4636

H81

ICPC

Excessive ear wax

1.3

30.4

2987

22258

N05BA01

ATC

diazepam; systemic, rectal

1.3

30.4

1906

13359

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

2.2

30.3

257

1080

R35

ICD-10 Finland

Polyuria

1.5

30.2

1109

7092

K80

ICPC

Cardiac arrhythmia NOS

1.4

30.0

1242

8121

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

30.0

554

3022

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

30.0

791

4718

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

29.9

2836

21033

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

3.7

29.9

244

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

55.3

29.9

292

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of familial hypercholesterolaemia

283.3

29.8

N05BA12

ATC

alprazolam; oral

1.4

29.8

1389

9277

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

29.7

435

2218

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

29.7

803

4815

XF600, ,

SPAT

1.8

29.7

434

2212

SPAT1304

SPAT

Counselling and guidance related to ageing

1.4

29.7

1307

8644

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.8

29.6

423

2141

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.4

29.6

199

756

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

29.4

428

2178

SPAT1240

SPAT

Therapeutic discussion

1.5

29.4

1060

6751

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.4

29.4

214

843

WX213

NOMESCO Finland

Lower leg blockade

2.8

29.4

147

482

PDQ20

NOMESCO Finland

Insertion of endovascular graft into common iliac artery

3.6

29.4

247

C07AB12

ATC

nebivolol; oral

1.8

29.3

436

2234

I70

ICD-10 Finland

Atherosclerosis

3.8

29.3

222

J01MA14

ATC

moxifloxacin; systemic

1.4

29.3

1345

8960

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

1.9

29.3

364

1762

PD3AT

NOMESCO Finland

Pelvic artery PTA

3.4

29.3

106

287

WX730

NOMESCO Finland

Conventional respirator

2.2

29.1

246

1032

TFP34

NOMESCO Finland

Electrophysiological investigation

1.8

29.1

452

2347

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

29.0

1557

10646

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.9

29.0

389

1931

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

29.0

1069

6841

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

28.8

837

5099

C08CA10

ATC

nilvadipine; oral

2.0

28.8

324

1515

WX199

NOMESCO Finland

Other local analgesia

1.7

28.7

533

2911

GD1AD

NOMESCO Finland

Thorax CT examination

1.5

28.7

915

5688

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

3.8

28.6

213

N03AX14

ATC

levetiracetam; systemic

1.9

28.6

391

1952

P06

ICPC

Sleep disturbance

1.4

28.6

1469

9972

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

6.9

28.5

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

3.3

28.5

111

315

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

28.5

2146

15437

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

28.4

1394

9392

M04AA03

ATC

febuxostat; oral

3.9

28.4

198

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

4.9

28.4

118

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

28.4

1186

7769

D01

ICPC

Abdominal pain/cramps general

1.4

28.3

1411

9531

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

28.3

3096

23352

2722A

ICD-9 Finland

Disorders of lipoid metabolism, Mixed hyperlipidaemia

+∞

28.3

R80

ICD-10 Finland

Isolated proteinuria

2.9

28.2

131

412

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.2

28.2

230

951

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

28.1

5420

43385

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

28.1

939

5893

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.8

27.9

441

2302

Z21

ICD-10 Finland

Asymptomatic human immunodeficiency virus [HIV] infection status

7.1

27.8

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.8

27.8

418

2149

PD1AE

NOMESCO Finland

Ultrasound examination of abdominal aortta

2.9

27.8

130

411

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.6

27.7

604

3440

XW000

NOMESCO Finland

Bone marrow biopsy

1.6

27.7

635

3662

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.0

27.6

314

1475

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

4.2

27.6

162

A10AA03, ,

ATC

2.9

27.6

128

403

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

27.5

834

5129

M01AB01

ATC

indometacin; systemic, rectal

1.4

27.4

1255

8354

R4190

NOMESCO Finland

Nutritional therapy

1.8

27.4

438

2295

A10BD03

ATC

metformin and rosiglitazone; systemic

2.1

27.4

251

1089

S16

ICPC

Bruise/contusion

1.7

27.3

463

2467

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

10.6

27.2

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

2.3

27.1

199

787

288

Kela drug reimbursment

Febuxostat

3.8

27.1

209

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

3.3

27.1

103

288

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.0

27.0

286

1309

E14.7

ICD-10 Finland

Unspecified diabetes mellitus, with multiple complications

11.6

27.0

C09DB01

ATC

valsartan and amlodipine; oral

1.7

27.0

527

2918

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

26.9

1879

13364

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

26.9

2252

16424

JN4AD

NOMESCO Finland

Body CT examination

1.3

26.8

1663

11628

I11

ICD-10 Finland

Hypertensive heart disease

3.0

26.7

117

356

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.3

26.7

206

833

R51

ICD-10 Finland

Headache

1.6

26.6

582

3318

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

26.6

927

5864

XA400

NOMESCO Finland

EEG

3.3

26.5

100

278

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

26.5

572

3251

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.7

26.5

479

2599

U07

ICPC

Urine symptom/complaint other

1.4

26.4

1084

7076

J45

ICD-10 Finland

Asthma

1.4

26.4

1358

9218

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

11.1

26.3

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

4.6

26.3

126

C09BA04

ATC

perindopril and diuretics; systemic

2.0

26.3

281

1292

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

26.2

1079

7046

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

3.4

26.1

258

N06AA12

ATC

doxepin; systemic

1.5

26.1

752

4572

A97

ICPC

No disease

1.3

26.1

2596

19337

SPAT1336

SPAT

Request for examination

1.7

26.1

472

2560

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.1

26.1

257

1146

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.0

26.1

303

1434

A08

ICPC

Swelling

1.5

26.0

755

4598

WX882

NOMESCO Finland

High dependency care

1.8

26.0

385

1971

J01FA09

ATC

clarithromycin; systemic

1.2

26.0

4408

34797

H02AB07

ATC

prednisone; oral

1.3

26.0

2058

14894

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

2.9

25.9

125

402

I49.1

ICD-10 Finland

Atrial premature depolarization

1.6

25.9

554

3142

M01AE02

ATC

naproxen; oral, rectal

1.2

25.9

8649

72478

L08

ICPC

Shoulder symptom/complaint

1.2

25.9

3345

25679

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

25.8

3594

27810

R04.2

ICD-10 Finland

Haemoptysis

1.6

25.8

557

3168

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

4.0

25.7

167

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.8

25.7

360

1812

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.0

25.7

283

1315

H34.1

ICD-10 Finland

Central retinal artery occlusion

3.1

25.7

110

331

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

25.6

500

2769

C07AB05

ATC

betaxolol; oral

1.8

25.6

424

2244

B01AB04

ATC

dalteparin; parenteral

1.5

25.6

770

4726

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

25.6

1725

12203

R12

ICD-10 Finland

Heartburn

1.4

25.6

1060

6932

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

25.6

896

5676

D12

ICPC

Constipation

1.7

25.5

524

2943

SPAT1252

SPAT

Overall medication plan or its review

1.4

25.4

1086

7141

R06AE07

ATC

cetirizine; oral

1.2

25.4

6280

51298

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

25.3

3674

28545

J01FA10

ATC

azithromycin; systemic

1.2

25.3

8245

68908

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.7

25.3

486

2682

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

25.2

1727

12245

M01AX05

ATC

glucosamine; oral

1.2

25.2

3423

26408

D64.8

ICD-10 Finland

Other specified anaemias

2.0

25.2

274

1268

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.6

25.2

147

523

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

25.1

660

3933

H3602, E103,

ICD-10 Finland

6.6

25.1

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

6.5

25.0

WZB00, ,

SPAT

1.5

25.0

810

5049

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

2.9

25.0

120

385

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

25.0

1586

11120

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.6

25.0

650

3864

EBA30

NOMESCO Finland

Extraction of root of tooth

1.5

24.9

856

5400

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

24.9

1274

8638

ZPB22

NOMESCO Finland

Autograft of vein

3.3

24.9

271

SPAT1172

SPAT

Guidance concerning hydration

1.8

24.9

371

1905

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

24.7

371

1908

QDH05

NOMESCO Finland

Correction of deformity of toe nail

4.8

24.7

107

M65.3

ICD-10 Finland

Trigger finger

1.6

24.7

628

3715

N04BC05

ATC

pramipexole; oral

1.4

24.6

1173

7859

N05CF02

ATC

zolpidem; oral

1.3

24.6

2351

17419

N05CD07

ATC

temazepam; oral

1.3

24.6

1868

13436

U14

ICPC

Kidney symptom/complaint

2.1

24.6

226

982

C02DE04, ,

ATC

1.8

24.6

392

2053

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

24.5

3396

26246

SPAT1101

SPAT

Orthostatic test

1.5

24.5

730

4474

R52.0

ICD-10 Finland

Acute pain

1.8

24.4

388

2030

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.9

24.4

295

1416

J01MA06

ATC

norfloxacin; oral

1.3

24.4

1869

13460

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

3.1

24.4

105

317

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

1.9

24.4

309

1507

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

2.6

24.3

138

484

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

4.7

24.3

112

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

2.9

24.2

114

362

K29.8

ICD-10 Finland

Duodenitis

2.6

24.2

144

517

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

24.2

6552

53868

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

24.1

511

2892

R03BA02

ATC

budesonide; inhalant

1.3

24.1

2446

18257

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

4.4

24.0

128

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.5

24.0

726

4463

K85

ICPC

Elevated blood pressure

1.3

24.0

2612

19655

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.5

24.0

147

536

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

23.8

268

1255

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.5

23.8

152

565

342

Kela drug reimbursment

Dronedarone

2.5

23.8

145

527

L01

ICPC

Neck symptom/complaint

1.3

23.7

2028

14813

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.9

23.7

316

1566

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

1.9

23.7

297

1443

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

7.0

23.6

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

3.2

23.6

271

SPAT1079

SPAT

Echocardiography

2.1

23.6

216

938

C02CA01

ATC

prazosin; oral

2.0

23.5

248

1135

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

23.5

1533

10789

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.5

23.4

684

4173

AA9PW, ,

NOMESCO Finland

8.2

23.4

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.5

23.4

735

4554

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

44.5

23.3

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

4.7

23.2

109

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

23.2

806

5095

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

23.2

736

4568

SPAT1151

SPAT

Treatment of major wounds

2.2

23.2

194

812

I45.9

ICD-10 Finland

Conduction disorder, unspecified

2.4

23.2

155

589

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

9.2

23.2

P03

ICPC

Feeling depressed

1.5

23.2

829

5273

358

Kela drug reimbursment

liraglutide

3.3

23.1

251

A07AA02

ATC

nystatin; oral

1.5

23.1

874

5619

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.7

23.1

449

2486

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

1.9

23.0

305

1509

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.6

23.0

551

3214

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.3

23.0

1678

12001

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

1.8

22.9

327

1657

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

22.9

1067

7121

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.5

22.9

654

3971

XF409

NOMESCO Finland

Other special ECG

3.0

22.9

104

324

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

22.9

795

5027

FNE21

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery sequential

4.0

22.9

149

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.7

22.9

471

2647

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

22.9

1048

6975

H3603, E107,

ICD-10 Finland

8.6

22.8

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

22.8

1045

6953

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.5

22.8

778

4903

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

22.8

364

1909

L84

ICD-10 Finland

Corns and callosities

1.6

22.7

495

2823

N06AX12

ATC

bupropion; oral

1.6

22.7

584

3465

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.9

22.7

297

1465

M54.1

ICD-10 Finland

Radiculopathy

1.6

22.6

523

3025

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

22.6

993

6559

S10

ICPC

Boil/carbuncle

1.5

22.6

773

4875

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.5

22.5

612

3675

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

1.6

22.5

476

2693

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

2.7

22.5

125

434

RD112, ,

NOMESCO Finland

5.1

22.5

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

22.5

351

1828

I12.9

ICD-10 Finland

Hypertensive renal disease without renal failure

5.9

22.5

349

Kela drug reimbursment

Febuxostat

3.7

22.4

176

A10AD04

ATC

insulin lispro; parenteral

3.8

22.4

172

I95.2

ICD-10 Finland

Hypotension due to drugs

2.8

22.3

115

384

L86

ICPC

Back syndrome with radiating pain

1.5

22.3

828

5303

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.5

22.3

633

3838

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

4.1

22.3

140

C01BD07

ATC

dronedarone; oral

2.6

22.2

126

442

OAA67, ,

SPAT

0.7

22.2

652

8854

RS222, ,

NOMESCO Finland

2.3

22.2

170

686

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

22.2

1258

8668

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

22.1

1844

13420

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

2.5

22.1

136

497

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

1.7

22.1

405

2208

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

1.9

22.0

273

1322

I70.0

ICD-10 Finland

Atherosclerosis of aorta

3.2

22.0

259

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

3.0

21.9

288

C07AA07

ATC

sotalol; systemic

1.5

21.9

600

3610

T81.7

ICD-10 Finland

Vascular complications following a procedure, not elsewhere classified

3.7

21.9

179

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

3.1

21.9

279

I73.9

ICD-10 Finland

Peripheral vascular disease, unspecified

2.5

21.9

141

527

ZXD20

NOMESCO Finland

Day surgery

1.3

21.8

1766

12802

E10.01

ICD-10 Finland

Insulin-dependent diabetes diabetic coma with hyperglycemia

7.2

21.8

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.6

21.8

483

2766

A10BX09

ATC

[U] dapagliflozin

2.5

21.7

137

507

W19

ICD-10 Finland

Unspecified fall

1.3

21.7

1405

9878

D07AD01

ATC

clobetasol; topical

1.3

21.7

2407

18138

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

21.6

851

5514

N03AX09

ATC

lamotrigine; oral

1.7

21.6

426

2369

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.8

21.5

341

1784

TQW80

NOMESCO Finland

Local dermatologic skincare

1.7

21.5

396

2161

CKD40

NOMESCO Finland

Endophotocoagulation of retina

2.0

21.5

238

1109

PEN25

NOMESCO Finland

Plastic repair of superficial femoral artery

3.6

21.5

177

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

21.5

1106

7504

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

1.9

21.4

282

1394

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

2.1

21.4

200

876

S76

ICPC

Skin infection other

1.5

21.4

744

4708

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.8

21.3

305

1547

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.3

21.3

166

675

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.1

21.3

215

969

PG1CG

NOMESCO Finland

Extensive MRI examination of vasculature with high intensity magnet not elsewhere classified

5.4

21.3

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.1

21.3

214

963

D68.8

ICD-10 Finland

Other specified coagulation defects

2.5

21.3

136

506

S20

ICPC

Corn/callosity

1.8

21.3

309

1575

B03BA03

ATC

hydroxocobalamin; parenteral

1.4

21.3

845

5482

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

21.2

995

6648

PA6BM

NOMESCO Finland

MRI examination of neck vasculature with 3 Tesla magnet

7.2

21.0

I20.11

ICD-10 Finland

Angina angiospastic

7.2

21.0

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

21.0

1678

12140

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

2.7

21.0

116

402

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.6

21.0

519

3051

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.5

21.0

592

3586

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.5

20.9

598

3635

K43

ICPC

Cardiovascular, Other diagnostic procedure

2.2

20.9

170

705

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

2.9

20.8

312

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

20.8

3678

29061

PD3BT

NOMESCO Finland

Pelvic artery extensive PTA

4.4

20.8

108

Y94.0

ICD-10 Finland

Accident at home

1.9

20.8

261

1271

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.7

20.8

422

2365

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

5.6

20.7

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.8

20.7

296

1502

SPAT1058

SPAT

PEF monitoring instruction

1.4

20.7

1200

8297

C10AA06

ATC

cerivastatin; oral

3.4

20.7

204

B01AF03

ATC

edoxaban; oral

1.7

20.7

373

2025

M01AX17

ATC

nimesulide; oral

1.2

20.7

3916

31136

E11.09

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - With coma

4.2

20.7

124

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

17689

141730

2.50

323.31

6.6

4.4

1.33

1.46

mmol/l

307.65

16260

127832

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

17780

143086

2.52

315.85

6.6

4.4

4.21

4.64

mmol/l

307.65

16455

129943

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2856

12562

2.28

313.65

5.1

3.3

1.22

1.23

mmol/l

3.37

2580

10702

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5272

29178

1.91

310.95

1.9

1.6

1.31

1.36

mg/l

0.44

4096

22495

(3019550) Sodium [Moles/volume] in Serum or Plasma

18567

152960

3.15

308.57

28.0

16.1

139.58

139.77

mmol/l

19.84

18273

148557

(3018095) Leukocytes [#/volume] in Urine

9006

51151

2.15

307.65

5.0

3.5

98.03

112.47

e6/l

0.49

6929

36975

(3015736) pH of Urine

8868

56003

1.83

307.65

4.3

3.5

5.74

5.80

0.55

269

3197

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

18058

143811

2.94

307.65

22.7

14.1

24.10

25.87

mg/l

10.59

15739

114030

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

10604

57896

2.49

307.65

5.6

3.4

68.41

60.21

ng/l

0.39

8507

42532

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

16948

130069

2.46

307.65

5.7

4.4

2.02

2.13

mu/l

1.81

15498

116046

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

15631

114602

2.25

307.65

8.8

7.3

81.61

79.39

u/l

5.57

14802

106983

(3009508) Creatinine [Moles/volume] in Urine

8410

46589

2.16

307.65

3.9

3.0

7.27

7.62

mmol/l

11.69

6915

38375

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4766

22212

2.29

307.65

3.6

3.1

0.82

mmol/l

0.83

4444

20591

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

17401

136894

2.49

307.65

5.9

4.0

1.48

1.27

mmol/l

139.79

15857

122335

(3026782) Osmolality of Urine

6083

29013

2.35

307.65

4.0

2.8

532.32

558.14

mosm/kgh2o

3.13

5396

24761

(3013512) EKG study

7894

46653

1.93

307.65

5.8

3.8

—

(3008037) Lactate [Moles/volume] in Venous blood

1276

3105

3.98

307.65

4.0

2.9

1.60

1.63

mmol/l

0.42

1265

3035

(3006504) Eosinophils/100 leukocytes in Blood

9923

65344

1.80

307.65

6.9

5.9

2.85

2.89

0.81

9292

60444

(3001604) Monocytes [#/volume] in Blood

10450

70079

1.80

307.65

6.5

5.6

0.64

0.60

e9/l

25.68

8982

60193

(3013826) Glucose [Moles/volume] in Serum or Plasma

13855

86223

2.63

307.65

6.1

4.3

7.20

6.76

mmol/l

83.17

13263

80759

(3000850) Epithelial cells [#/volume] in Urine

5724

31666

1.94

307.65

3.4

2.5

4.77

4.85

e6/l

0.19

5197

28202

(3035350) Ketones [Presence] in Urine by Test strip

10719

70258

1.89

307.65

4.9

3.7

0.00

estimate

0.64

2564

14154

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9322

45510

2.69

307.65

3.6

2.8

1854.10

1380.89

ng/l

11.69

8119

38972

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

18112

146452

2.78

307.65

7.4

4.9

2.38

2.74

mmol/l

307.65

16761

132143

(3022948) Iron [Moles/volume] in Serum or Plasma

4701

21835

2.29

307.65

3.5

2.2

11.96

12.82

umol/l

13.27

4386

20106

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5142

21282

2.66

307.65

2.3

1.9

30.24

29.96

2.14

5031

20623

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4427

20161

2.32

307.65

3.5

2.2

2.29

2.30

g/l

0.45

4137

18433

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

9809

62228

1.90

307.65

2.3

1.9

94.26

94.88

pmol/l

0.61

5211

32108

(3009261) Glucose [Presence] in Urine by Test strip

10789

71100

1.88

307.65

4.9

3.7

0.00

estimate

0.30

2124

12914

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7343

42987

1.91

307.65

3.3

3.2

36.52

35.40

u/l

0.35

6934

40396

(3023368) Bacteria identified in Blood by Culture

7208

41256

1.96

307.65

5.1

4.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

13900

100359

1.94

307.65

5.6

4.2

—

(3019198) Lymphocytes [#/volume] in Blood

10681

71956

1.80

307.65

6.7

5.7

1.93

1.91

e9/l

0.28

9360

63193

(3021601) Nitrite [Presence] in Urine by Test strip

10707

70213

1.89

307.65

6.7

4.8

0.00

estimate

0.02

2308

13197

(3021589) Normoblasts [#/volume] in Blood

10285

62664

2.07

307.65

13.2

9.4

0.00

e9/l

0.38

8721

51590

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6422

35484

1.99

307.65

2.5

2.2

3.25

3.07

mg/l

6.20

5496

29955

(3014576) Chloride [Moles/volume] in Serum or Plasma

3857

18370

2.16

307.65

7.3

6.3

104.43

104.59

mmol/l

1.21

3852

18356

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4493

22851

2.05

307.65

3.6

2.9

2.47

2.24

e6/l

0.69

2745

12518

(3018010) Neutrophils/100 leukocytes in Blood

9980

66100

1.79

307.65

6.8

5.8

58.87

57.72

17.46

9358

61311

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4344

17372

2.67

307.65

9.0

4.8

1.06

1.02

mmol/l

19.21

4089

15974

(3020682) Albumin/Creatinine [Ratio] in Urine

9179

47854

2.44

307.65

4.9

3.6

14.61

6.73

mg/mmol

29.58

6255

29346

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

12087

74417

2.29

307.65

9.2

5.8

1.21

mmol/l

10.70

9984

62342

(3013707) Erythrocyte sedimentation rate by Westergren method

14661

107384

2.01

307.65

4.8

4.1

15.24

12.85

mm/h

52.14

13491

97935

(3013115) Eosinophils [#/volume] in Blood

10752

72523

1.81

307.65

6.8

5.8

0.20

e9/l

4.60

9352

63162

(3020779) Urea [Moles/volume] in Serum or Plasma

3099

12186

2.59

307.65

11.0

5.9

11.57

9.96

mmol/l

25.64

2944

11503

(3022096) Basophils/100 leukocytes in Blood

9697

63285

1.81

307.65

6.9

5.9

0.65

0.67

3.49

9067

58453

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

11578

76541

1.96

307.65

6.1

6.2

11.60

12.00

umol/l

2.60

10979

72429

(3018418) pH of Serum or Plasma

7469

43385

1.94

307.65

5.6

3.7

7.40

2.44

1903

8322

(40760892) CBC W Ordered Manual Differential panel - Blood

9916

65857

1.78

307.65

7.2

6.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4203

18974

2.32

307.65

3.6

2.3

21.08

22.54

9.77

3797

15906

(3002030) Lymphocytes/100 leukocytes in Blood

10147

67200

1.81

307.65

7.1

6.0

25.96

27.06

18.20

9523

62405

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10638

67889

1.96

307.65

8.2

5.2

1.21

mmol/l

4.77

9790

60946

(1761482) Bacteria [#/volume] in Urine by Culture

1355

3964

3.31

307.65

4.6

4.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

2849

10331

2.80

307.65

4.2

2.7

4.66

4.51

kpa

2.58

2769

10003

(3004119) Hemoglobin [Mass/volume] in Venous blood

2201

8401

2.59

307.65

4.3

2.8

128.90

129.03

g/l

0.09

2176

8204

(3026008) Bacteria identified in Urine by Culture

7384

44956

1.82

307.65

3.7

3.1

—

(3006315) Basophils [#/volume] in Blood

10477

70304

1.80

307.65

6.5

5.6

0.04

e9/l

1.54

9009

60375

(3022217) INR in Platelet poor plasma by Coagulation assay

12557

72104

2.67

307.65

22.7

16.1

1.32

1.33

inr

0.18

3838

20425

(3019069) Monocytes/100 leukocytes in Blood

9965

65749

1.80

307.65

7.2

6.2

8.84

8.81

0.38

9339

60895

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

17679

136124

2.96

307.65

9.4

5.7

43.79

39.91

mmol/mol

307.65

16383

123478

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1902

6373

2.93

307.65

5.6

3.4

46.50

48.00

1.70

1889

6305

(3030467) Casts [#/volume] in Urine by Automated count

7336

41320

2.01

307.65

4.0

3.0

0.43

0.45

e6/l

0.42

5884

31704

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

8809

43880

2.54

307.65

2.6

2.0

206.36

216.70

u/l

0.37

8215

40723

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3284

12552

2.69

307.65

5.0

3.2

5.80

5.84

kpa

1.08

3212

12204

(3012516) Albumin [Mass/volume] in Urine

8447

45446

2.25

307.65

3.9

3.1

376.53

383.71

mg/l

0.05

5734

28344

(3002032) Base excess in Venous blood by calculation

3285

12497

2.70

307.65

5.1

3.2

1.72

1.99

mmol/l

4.08

2786

10639

(3012544) pH of Venous blood

3375

13003

2.68

307.65

4.9

3.3

7.38

0.08

(36304419) Bacteria [Presence] in Urine

6792

39877

1.87

307.65

4.0

3.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

14375

105241

1.96

307.65

4.5

3.7

15.02

14.96

pmol/l

2.39

12939

93347

(3038515) Glucose [Moles/volume] in Venous blood

1252

2945

4.11

307.65

4.1

3.0

7.97

7.59

mmol/l

3.40

1242

2885

(3002582) Erythrocytes [#/volume] in Urine

8157

44674

2.16

307.65

4.3

3.1

69.32

115.89

e6/l

2.84

6654

34331

(3024561) Albumin [Mass/volume] in Serum or Plasma

10252

64070

1.99

307.65

5.6

4.5

34.81

35.11

g/l

5.82

9504

59040

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8674

53452

1.88

307.65

3.7

2.6

156.51

158.68

ug/l

0.26

7880

48393

(3026493) Urate [Moles/volume] in Serum or Plasma

6722

39002

1.89

307.65

3.5

2.6

8246.12

4910.93

umol/l

5.07

5757

33485

(3027273) Bicarbonate [Moles/volume] in Venous blood

1908

6831

2.74

307.65

4.3

2.9

25.25

25.31

mmol/l

0.31

1882

6652

(3013650) Neutrophils [#/volume] in Blood by Automated count

11661

81904

1.76

307.19

9.2

8.9

4.47

4.14

e9/l

34.42

10175

71320

(3023103) Potassium [Moles/volume] in Serum or Plasma

18581

153339

3.15

303.49

28.3

16.2

4.02

3.99

mmol/l

42.63

18268

148676

(3021960) Folate [Moles/volume] in Serum or Plasma

6028

35167

1.83

298.95

1.7

1.5

19.84

20.48

nmol/l

1.79

5162

29374

(3044889) 12 lead EKG panel

14052

104797

1.82

295.18

5.5

3.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

17275

138379

2.24

290.14

22.1

13.3

72.17

77.13

ml/min/173m2

152.70

14919

114312

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1970

7602

2.54

288.33

3.7

2.5

0.23

0.29

e6/l

1.39

1940

7435

(3000330) Specific gravity of Urine by Test strip

1937

7426

2.55

287.35

4.6

3.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2327

9754

2.36

284.08

5.8

3.2

119.85

88.53

ng/l

26.52

1957

8231

(3002385) Erythrocyte distribution width [Ratio]

15674

121505

1.93

283.84

27.1

16.5

15.04

15.40

8.11

15485

118940

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8651

56711

1.72

282.67

2.7

2.1

76.39

79.64

nmol/l

22.14

7640

49515

(3033705) Calcium.ionized [Moles/volume] in Venous blood

783

1749

4.25

282.20

2.8

2.3

—

(3041354) Potassium [Moles/volume] in Venous blood

788

1773

4.22

281.31

2.8

2.3

4.10

4.06

mmol/l

1.07

783

1756

(3035285) Chloride [Moles/volume] in Venous blood

788

1773

4.22

281.31

2.8

2.3

105.87

105.74

mmol/l

0.31

783

1755

(3041096) Erythrocytes [Presence] in Urine by Automated

6136

36525

1.79

281.10

5.0

3.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

3431

16889

2.05

280.22

2.7

2.4

1.84

1.74

6.95

3045

14779

(3031040) Bacteria [#/volume] in Urine by Automated count

13126

96661

1.75

278.66

5.9

4.4

1159.55

1543.46

e6/l

0.62

439

1293

(3033658) Prothrombin time (PT) actual/Normal

6014

35918

1.78

270.19

4.5

3.8

86.26

87.20

1.84

5863

35063

(3019309) Folate [Moles/volume] in Red Blood Cells

5207

29787

1.83

270.16

1.9

1.7

1190.16

1159.36

nmol/l

1.36

3885

22135

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1136

3417

3.19

263.92

3.6

2.8

24.31

25.05

mmol/l

6.59

1114

3345

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3197

15667

2.05

262.73

4.2

3.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7241

46029

1.71

257.86

3.0

2.5

57.59

64.09

u/l

1.76

6656

42057

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4544

25261

1.85

256.48

3.2

2.7

1.29

1.22

e6/l

0.18

2780

14804

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2134

8995

2.33

255.76

4.3

3.3

5.08

5.17

kpa

5.29

2015

8445

(3009343) pH of Capillary blood

2108

8870

2.33

253.54

4.3

3.3

7.41

7.42

5.75

354

1111

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

17523

142787

2.20

253.13

6.4

4.7

6.43

5.99

mmol/l

227.54

15838

127726

(3020630) Protein [Mass/volume] in Serum or Plasma

2682

12481

2.13

252.09

2.8

2.5

66.08

66.59

g/l

2.79

2448

11220

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

9725

67164

1.66

250.02

2.9

2.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2044

8564

2.34

248.01

4.2

3.2

1.64

1.89

mmol/l

1.97

1437

6468

(3000991) Gas panel - Venous blood

2506

11489

2.15

244.24

9.5

7.3

—

(3044640) Blood type and Crossmatch panel - Blood

7109

45592

1.68

240.50

2.8

2.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

12005

88204

1.65

235.40

3.6

3.0

62.99

52.30

u/l

16.13

10986

80554

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

18471

154757

2.66

235.14

14.3

10.3

27.24

26.04

u/l

10.05

17863

147851

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1946

8225

2.31

230.59

7.5

6.3

24.49

24.88

mmol/l

4.65

1925

8138

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4805

27948

1.77

229.54

5.0

3.5

475.47

550.99

ng/l

0.41

4131

22845

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5430

32805

1.72

226.28

1.9

1.7

13231971.74

33582298.15

pmol/l

2.99

4323

26422

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2760

13500

2.03

225.10

2.6

2.2

7.43

7.41

ug/l

0.01

2407

11724

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2263

10280

2.16

224.62

2.1

2.3

364.40

367.46

nmol/l

0.26

2078

9439

(1616796) Gas panel - Central venous blood

996

3046

3.12

224.41

4.2

3.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1098

3558

2.95

223.65

2.6

2.2

156.97

91.99

ug/min

3.27

712

1975

(40761511) CBC panel - Blood by Automated count

17965

149279

2.26

221.69

22.1

13.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1616

6470

2.42

216.02

3.3

2.3

0.68

0.65

4.39

1608

6441

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1632

6603

2.39

213.01

3.3

2.3

1.18

1.24

1.56

1621

6569

(3015377) Calcium [Moles/volume] in Serum or Plasma

7531

50274

1.61

209.38

3.4

2.35

mmol/l

1.12

6493

43521

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8089

54947

1.60

209.13

5.3

3.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3282

17444

1.88

208.21

3.6

4.3

242.72

246.70

u/l

0.90

3100

16463

(3028626) Oxygen [Partial pressure] in Capillary blood

951

2964

3.05

207.17

3.3

2.7

8.09

7.98

kpa

1.24

932

2899

(3021901) Oxygen saturation in Capillary blood

853

2524

3.21

202.82

3.2

2.6

—

(1761868) Lipid panel - Serum or Plasma

6959

45899

1.61

201.15

4.9

2.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2502

12367

1.99

196.16

7.7

6.1

1.36

1.37

mmol/l

0.04

2439

12019

(40767503) Oxygen content in Capillary blood by calculation

947

3063

2.94

193.06

2.8

2.3

16.00

16.37

1.74

556

1496

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1489

6053

2.37

191.60

5.9

3.5

23.76

24.23

mmol/l

6.52

1453

5923

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

830

2523

3.12

188.49

2.6

1.6

0.89

0.82

nmol/l

1.73

686

2101

(3004588) Protein electrophoresis panel - Serum or Plasma

2166

10342

2.04

186.50

2.3

2.4

—

(3003396) Base excess in Arterial blood by calculation

3108

16840

1.83

183.19

7.4

6.5

0.98

1.14

mmol/l

1.45

2491

13456

(3009542) Hematocrit [Volume Fraction] of Blood

18680

159809

2.56

179.12

34.1

21.0

39.18

40.37

37.82

17858

147921

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

970

3316

2.78

178.35

4.1

2.7

1.88

1.56

mg/l

18.72

880

2996

(3007461) Platelets [#/volume] in Blood

18683

159887

2.56

178.21

33.8

20.9

241.09

243.61

e9/l

5.53

18294

154814

(3010813) Leukocytes [#/volume] in Blood

18685

159977

2.55

176.77

33.9

20.9

7.16

6.72

e9/l

81.44

18227

154257

(3035941) MCH [Entitic mass]

18682

159948

2.54

176.58

33.7

20.8

30.37

30.45

7.45

18464

156868

(3024731) MCV [Entitic volume]

18684

159976

2.55

176.52

33.8

20.8

91.59

91.48

2.22

18466

156881

(3016502) Oxygen saturation in Arterial blood

2836

15101

1.85

176.20

7.7

6.8

94.99

95.57

4.26

2743

14544

(3026361) Erythrocytes [#/volume] in Blood

18683

159985

2.54

176.04

33.9

20.9

4.42

4.49

e12/l

60.00

18212

154259

(3000963) Hemoglobin [Mass/volume] in Blood

18685

160012

2.54

176.00

34.1

21.0

133.04

135.81

g/l

106.31

18477

156935

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1528

6531

2.25

174.36

1.7

1.6

1.59

1.56

g/l

0.85

1304

5506

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

733

2170

3.19

173.86

5.4

2.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1260

5011

2.40

169.71

3.2

2.7

0.37

0.35

u/ml

1.26

751

2847

(3021440) Promyelocytes/100 leukocytes in Blood

2319

11748

1.93

167.43

3.9

4.0

0.10

0.11

0.31

743

3753

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3059

16916

1.79

167.06

7.5

6.5

5.06

5.10

kpa

2.02

2921

16125

(3027801) Oxygen [Partial pressure] in Arterial blood

3054

16905

1.78

166.14

7.5

6.5

11.55

12.27

kpa

12.46

2916

16103

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3990

23839

1.68

164.81

2.0

1.8

—

(3023520) Reticulocytes [#/volume] in Blood

2471

12856

1.88

164.27

2.5

2.6

71.85

67.95

e9/l

6.26

1858

9919

(3042936) Bacteria identified in Isolate by Culture

3574

20750

1.72

164.19

2.3

1.9

—

(3025159) Blasts/100 leukocytes in Blood

2200

11036

1.94

163.31

3.9

4.0

0.32

0.37

0.09

623

3102

(3017181) Myelocytes/100 leukocytes in Blood

2389

12395

1.88

159.89

4.0

3.9

0.90

0.98

0.71

810

4374

(3004775) Volume in Urine collected for unspecified duration

481

1160

3.89

155.75

2.5

2.1

680.23

668.99

0.22

335

733

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1364

5821

2.24

155.67

4.0

4.8

1.49

1.67

8.72

1321

5437

(3027315) Oxygen [Partial pressure] in Blood

932

3375

2.62

152.75

4.8

3.7

8.55

8.50

kpa

0.35

911

3289

(3013290) Carbon dioxide [Partial pressure] in Blood

927

3352

2.62

152.38

4.7

3.7

4.97

5.01

kpa

0.66

906

3266

(3012501) Base excess in Blood by calculation

926

3351

2.62

151.97

4.7

3.7

2.44

2.55

mmol/l

0.53

610

2289

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5692

37810

1.54

148.60

1.8

1.6

1.56

1.31

mmol/l

33.30

4586

30641

(3007930) Methemoglobin/Hemoglobin.total in Blood

1331

5742

2.22

147.73

4.0

4.8

0.81

0.89

15.34

1292

5358

(3010421) pH of Blood

1003

3856

2.47

145.01

4.8

3.6

7.42

2.48

948

3514

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2542

13830

1.79

144.94

8.1

7.2

120.55

121.68

g/l

1.90

2492

13451

(3007164) IgA [Mass/volume] in Serum or Plasma

3741

22685

1.64

143.26

1.6

1.5

2.58

2.61

g/l

0.30

2224

13129

(3040151) Glucose [Moles/volume] in Capillary blood

538

1504

3.36

139.83

13.0

9.7

7.74

7.35

mmol/l

1.28

465

1216

(3007853) Bacteria identified in Skin by Aerobe culture

2919

16722

1.71

138.37

2.1

1.7

—

(40758558) Short blood count panel - Blood

5366

35662

1.53

137.59

6.7

6.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

876

3244

2.55

136.94

2.4

2.1

127.13

129.87

g/l

2.12

692

2273

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1980

10135

1.89

136.91

1.7

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1282

5625

2.17

136.12

2.2

7.63

7.37

g/l

5.68

1149

4983

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1280

5619

2.17

135.73

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1278

5610

2.17

135.53

2.2

3.80

3.73

g/l

0.79

1147

4968

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2808

16059

1.71

133.51

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2813

16096

1.71

133.49

1.9

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1091

4526

2.29

132.69

3.0

3.2

8.17

4.30

ratio

0.35

106

338

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1855

9391

1.90

132.46

9.5

8.0

0.64

0.68

4.60

1838

9337

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1112

4674

2.26

131.06

3.1

3.3

45.80

42.94

mg/l

0.24

852

3743

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1853

9424

1.89

130.38

9.4

7.9

1.35

1.38

0.84

1834

9365

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1674

8239

1.95

129.94

1.6

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1109

4678

2.25

129.57

3.1

3.3

61.62

60.26

mg/l

0.06

850

3731

(40768797) Stomach Pathology biopsy report

3284

19807

1.63

126.68

1.3

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

2881

16864

1.67

124.81

1.3

465.24

536.21

titre

1.40

618

3687

(40761536) Microorganisms panel - Urine sediment

2263

12404

1.77

124.48

5.2

3.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1319

6067

2.07

123.56

1.9

2.13

2.32

ug/l

0.23

1177

5321

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1545

7606

1.94

119.44

9.7

8.3

24.18

24.40

mmol/l

1.83

1478

7327

(3002179) Metamyelocytes/100 leukocytes in Blood

2086

11316

1.78

118.53

3.6

3.9

0.57

0.69

2.26

659

3756

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1171

5273

2.11

115.86

2.2

9.80

10.42

g/l

5.36

1025

4599

(3028271) Lactate [Moles/volume] in Capillary blood

661

2311

2.69

115.83

2.0

1.7

1.75

1.72

mmol/l

0.35

648

2243

(3016750) Collection duration of Urine

349

828

3.93

115.57

2.2

2.0

500.93

497.88

min

0.21

257

584

(3020876) Protein [Mass/time] in 24 hour Urine

493

1484

3.11

113.45

2.7

2.2

1.56

1.12

g/24h

2.10

303

656

(3051387) C reactive protein [Mass/volume] in Capillary blood

805

3132

2.42

113.00

4.1

3.3

26.96

28.94

mg/l

0.77

595

1919

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1658

8530

1.86

111.77

1.8

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4032

26181

1.53

111.15

1.3

1.2

1.29

1.81

u/ml

2.98

1128

6737

(3014007) Fractional oxyhemoglobin in Arterial blood

1791

9489

1.81

109.72

9.8

8.0

93.68

93.84

0.52

1784

9462

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1287

6132

2.00

109.03

1.5

1.6

16.07

17.36

u/ml

0.08

172

(3003181) Sodium [Moles/volume] in Urine

467

1406

3.11

107.42

1.4

1.2

56.97

68.49

mmol/l

7.93

385

1102

(3022313) Gas panel - Capillary blood

1352

6594

1.95

107.03

4.7

3.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1083

4893

2.10

106.01

2.5

2.2

448.34

583.06

ug/l

0.78

1032

4595

(3017143) Hepatitis C virus Ab [Presence] in Serum

2075

11589

1.72

105.76

2.1

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2607

15485

1.63

105.09

2.7

8.50

9.98

umol/l

2.49

2240

13541

(3036489) Thrombin time

1019

4527

2.13

104.19

2.2

1.9

22.00

21.80

0.33

886

3970

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1057

4769

2.10

103.80

2.5

2.4

0.83

1.11

g/l

1.18

886

3995

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

943

4080

2.18

103.10

2.4

2.2

0.03

g/l

0.06

848

3701

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4264

28435

1.49

102.07

3.1

3.2

2.46

mmol/l

1.82

3632

24954

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1133

5283

2.03

101.77

2.3

2.2

3.01

2.95

g/l

1.10

1000

4644

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1048

4775

2.08

100.20

1.7

1.6

237.44

248.36

titre

0.05

226

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2174

12472

1.68

100.00

2.7

2.4

52.76

51.65

u/l

0.02

1835

10655

(3029937) Albumin [Presence] in Urine by Test strip

5655

39924

1.43

99.80

5.2

4.1

0.00

estimate

0.50

2107

12638

(3026250) Tacrolimus [Mass/volume] in Blood

221

416

4.93

98.08

41.8

29.2

7.32

7.20

ug/l

0.32

208

366

(3028026) IgM [Mass/volume] in Serum or Plasma

1444

7430

1.85

96.78

2.0

1.20

1.44

g/l

2.63

1296

6725

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

877

3824

2.16

93.91

2.4

2.2

0.00

g/l

0.50

786

3457

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

889

3917

2.14

92.68

1.3

1.2

—

(3004451) EKG impression Narrative

280

665

3.92

92.62

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

863

3761

2.16

92.51

2.4

2.2

0.00

g/l

-0.00

785

3449

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

955

4364

2.07

90.43

2.4

2.1

37.16

37.54

g/l

1.12

818

3714

(3005719) IgG [Mass/volume] in Serum or Plasma

1743

9684

1.72

89.76

2.7

2.8

10.29

10.72

g/l

3.08

1574

8842

(40760888) Immunoglobulin light chains.free panel - Serum

818

3551

2.17

88.51

3.0

3.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

519

1871

2.60

85.45

2.0

1.7

89.22

89.50

0.44

513

1837

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

682

2800

2.29

84.50

1.2

70.00

145.80

titre

—

(3000012) Reticulocyte production index

581

2223

2.45

84.41

2.0

2.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1296

6721

1.83

84.33

2.9

3.0

4.29

4.43

pmol/l

4.67

1146

5906

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

9315

72748

1.34

83.39

2.5

2.4

—

(3011985) Renin [Units/volume] in Plasma

434

1447

2.80

83.22

1.4

1.3

97.70

55.88

mu/l

2.31

377

1280

(40768446) Kidney Pathology biopsy report

197

393

4.65

81.69

1.8

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

4762

33734

1.39

78.57

4.1

3.8

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

424

1442

2.74

78.31

3.3

2.0

13.94

6.38

titre

0.70

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4953

35343

1.39

78.17

2.7

2.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2150

13043

1.58

77.69

3.0

2.7

270.22

215.15

ng/l

4.61

2005

11888

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2070

12467

1.59

77.11

1.9

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

410

1389

2.75

76.29

1.4

1.3

352.69

279.96

pmol/l

0.67

350

1199

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1643

9406

1.66

75.05

7.2

6.6

24.50

24.69

mmol/l

1.23

1585

8962

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

494

1870

2.47

73.43

1.1

987.69

5863.54

iu/ml

0.42

403

(46235355) HIV 1 and 2 tests - Meaningful Use set

2311

14420

1.54

73.43

1.9

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

796

3692

2.03

72.17

2.4

2.1

93.64

89.12

6.91

768

3536

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

899

4395

1.92

70.04

1.9

1.6

—

(3024928) Oxygen saturation in Venous blood

623

2666

2.19

69.76

3.8

2.7

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

352

1159

2.83

69.12

2.5

2.2

—

0.16

—

(3037121) Protein [Mass/volume] in Urine

973

4923

1.86

68.20

4.3

2.8

0.35

0.28

g/l

2.01

567

1978

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

810

3864

1.97

67.79

1.4

11.85

15.06

iu/ml

0.48

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

763

3571

2.01

67.42

1.5

0.25

0.23

g/l

9.89

720

3373

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

428

1580

2.53

67.11

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

451

1707

2.47

67.07

1.3

0.19

0.25

nmol/l

0.93

125

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

781

3697

1.98

66.82

1.5

1.22

1.16

g/l

4.75

734

3512

(3018405) Lactate [Moles/volume] in Arterial blood

1048

5477

1.80

66.11

4.4

3.8

1.41

1.36

mmol/l

0.66

1019

5405

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

449

1710

2.45

65.88

1.3

4.82

1.69

nmol/l

0.52

432

1645

(3025941) Bacteria identified in Stool by Culture

1275

7056

1.71

65.87

1.3

1.2

—

(3012565) Volume of 24 hour Urine

234

622

3.49

65.84

2.2

2.1

1877.24

1930.86

0.32

204

528

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8199

64220

1.30

65.72

5.2

5.1

2.96

3.58

ug/l

1.31

7219

57393

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

111

159

6.46

65.67

15.5

9.9

5.29

5.68

mmol/l

0.43

111

159

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

538

2248

2.24

63.86

1.8

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

495

2003

2.31

63.40

1.8

1.3

111.45

120.13

u/ml

0.95

135

450

(3037756) Immunofixation for Serum or Plasma

682

3135

2.04

63.32

1.4

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

764

3692

1.94

61.53

2.8

2.3

3.79

3.62

g/l

2.36

730

3521

(3036603) Volume of Urine

254

744

3.17

61.28

1.5

1.6

1869.78

1844.08

0.19

245

715

(3042733) HLA Ab [Presence] in Serum

156

326

4.43

61.19

5.9

4.5

—

(3052851) Hemolysis interference index of Serum or Plasma

856

4309

1.87

60.88

3.8

3.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

395

1478

2.49

60.22

2.0

1.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3220

22239

1.40

59.30

1.3

35.48

37.96

iu/ml

0.39

921

7095

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

713

3428

1.95

58.27

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2116

13600

1.48

57.42

2.1

2.2

0.21

g/l

4.40

1933

12615

(3003338) MCHC [Mass/volume]

13833

116972

1.30

56.79

29.0

18.7

331.19

332.32

g/l

40.63

13726

115941

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

725

3538

1.92

56.68

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1306

7607

1.62

55.12

1.8

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

2201

14366

1.46

55.08

2.1

2.2

158.61

149.31

ug/g

0.48

1732

11143

(3023183) Ammonium ion [Moles/volume] in Plasma

598

2763

2.02

54.72

2.3

2.5

30.87

34.54

umol/l

3.54

525

2458

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

689

3348

1.93

54.55

2.8

2.4

205.73

197.63

1.50

657

3161

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1014

5549

1.72

54.35

1.9

1.8

37.17

39.24

u/l

2.34

842

4840

(3022145) Colonoscopy Study observation

2463

16459

1.43

54.29

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

386

1506

2.39

53.76

1.3

—

nmol/l

—

(3019060) Gas panel - Arterial blood

1645

10173

1.53

53.52

4.5

4.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1311

7704

1.61

53.30

10.7

9.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1042

5777

1.70

53.23

5.1

3.5

24.40

25.03

mmol/l

10.26

957

5284

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

511

2256

2.11

52.84

1.7

1.3

15.97

18.49

u/ml

0.18

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

461

1979

2.17

51.22

3.3

2.4

344.07

6623.15

u/ml

0.88

132

(3010375) cycloSPORINE [Mass/volume] in Blood

188

511

3.41

51.21

26.0

29.2

100.64

114.08

ug/l

2.80

141

446

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

554

2602

1.99

48.42

8.1

4.9

2397.38

1300.66

iu/ml

0.36

120

391

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2085

13807

1.44

47.89

1.6

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

783

4131

1.78

47.66

1.5

1.4

265.28

267.86

ug/g

0.13

468

2439

(4094501) Cardiovascular stress test using bicycle ergometer

749

3921

1.79

46.81

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

206

627

3.05

46.69

1.8

1.9

—

(3043409) Potassium [Moles/volume] in Arterial blood

874

4787

1.71

46.61

4.7

4.0

3.95

3.89

mmol/l

3.06

862

4755

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

438

1915

2.13

46.47

1.4

1.2

288.09

289.41

u/ml

0.03

301

1201

(3048929) Epstein Barr virus Ab [Presence] in Serum

565

2736

1.93

45.19

1.4

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

589

2901

1.90

44.76

1.4

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

650

3313

1.83

44.36

3.1

0.81

0.80

nmol/l

0.24

515

2561

(3000494) Fungus identified in Specimen by Culture

2455

16939

1.38

44.25

1.5

1.4

—

(3019977) pH of Arterial blood

226

750

2.79

43.89

2.2

2.4

7.43

7.42

0.46

302

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

247

860

2.66

43.74

1.3

1.2

9.47

9.14

mmol/l

0.56

234

806

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2469

17083

1.38

43.71

3.5

4.2

33.84

24.36

ug/l

0.32

2015

14113

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1347

8341

1.52

43.24

2.6

2.4

—

(3019150) Specific gravity of Urine by Refractometry

4227

31671

1.29

43.06

5.0

4.2

1.02

kg/l

1.01

755

4692

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2940

20964

1.34

42.79

1.3

1.2

15.78

14.51

u/ml

0.17

1112

7739

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

452

2065

2.04

42.70

1.4

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

461

2132

2.01

42.11

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

150

5.30

41.77

6.3

4.4

—

(3024932) HLA-DR beta [Type]

137

347

3.65

41.59

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

260

953

2.53

41.52

1.1

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

485

2296

1.97

41.47

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

264

976

2.51

41.41

2.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

282

1078

2.43

41.18

1.3

1.2

—

u/ml

—

(3000034) Microalbumin [Mass/volume] in Urine

316

1271

2.31

41.15

3.7

2.7

121.10

27.04

mg/l

2.93

229

883

(3024471) HLA-A [Type]

139

360

3.57

40.84

1.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1856

12382

1.42

40.54

3.2

2.6

54.04

64.53

ml/min/173m2

27.33

914

4803

(21494755) Public health laboratory ask at order entry panel

554

8987

0.55

40.38

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

627

3260

1.80

40.08

1.2

724.17

982.29

titre

0.51

105

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

291

1151

2.35

39.40

1.3

1.2

1.54

1.40

nmol/l

1.34

261

1040

(40768804) Tissue Pathology biopsy report

7363

59280

1.23

39.37

2.2

2.1

—

(3003694) ABO and Rh group [Type] in Blood

4772

36642

1.26

39.19

1.4

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

627

3291

1.78

38.83

1.2

153.58

146.67

titre

0.06

261

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

598

3096

1.80

38.78

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

598

3096

1.80

38.78

1.3

—

(3016038) Potassium [Moles/volume] in Urine

164

492

3.09

38.19

1.1

32.79

36.93

mmol/l

1.42

139

412

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

164

493

3.08

38.06

2.8

2.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

480

2335

1.91

37.91

1.3

35.97

40.12

u/l

0.37

416

2009

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

796

4513

1.65

37.20

1.7

1.6

—

(3049717) Cytology report of Urine Cyto stain

1101

6744

1.53

37.05

2.7

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

132

363

3.36

35.46

2.0

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

132

363

3.36

35.46

2.0

2.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

832

4846

1.61

34.87

1.2

1.31

0.85

u/ml

0.35

451

(3003434) Protein [Mass/volume] in Pleural fluid

453

2223

1.90

34.86

1.5

1.4

30.65

33.29

g/l

3.97

401

1999

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

328

1441

2.11

34.47

1.2

56.46

64.15

u/l

1.36

290

1277

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

301

1280

2.18

34.37

3.3

1.7

3763.20

2305.45

titre

0.30

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

342

1533

2.07

34.09

1.1

120.97

115.55

2.65

317

1370

(3004809) Band form neutrophils/100 leukocytes in Blood

493

2510

1.83

33.81

3.4

1.39

1.52

0.31

430

2212

(3014148) Varicella zoster virus Ab [Titer] in Serum

272

1119

2.25

33.68

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1375

8979

1.44

33.56

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

117

310

3.49

33.31

1.1

—

(3020891) Body temperature

1033

6389

1.52

33.18

5.6

4.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

180

616

2.70

33.09

1.3

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

359

1658

2.01

33.00

1.3

1.2

4.00

4.41

u/ml

0.14

118

581

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

411

1990

1.92

32.96

1.5

—

(4146454) Self-monitoring of blood glucose

365

1697

2.00

32.93

3.1

2.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

1139

7218

1.48

32.48

1.3

224.08

261.38

u/ml

0.77

1045

6629

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

120

329

3.37

32.43

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

331

1499

2.05

32.13

4.0

3.1

—

(3022621) pH of Urine by Test strip

1443

9599

1.41

31.74

3.4

3.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

131

389

3.11

31.13

1.2

161.34

162.53

mmol/24h

0.05

131

389

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

346

1614

1.99

30.95

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

794

4706

1.58

30.90

1.7

1.5

—

(3008295) Osmolality of Serum or Plasma

229

918

2.31

30.19

1.3

280.70

285.15

mosm/kgh2o

1.66

179

677

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

192

711

2.50

30.15

4.5

2.8

—

(3022689) Creatine [Moles/volume] in Urine

120

345

3.21

30.10

1.5

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

287

1265

2.10

29.97

2.4

2.1

1.99

2.28

u/field

0.33

115

469

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

401

1994

1.87

29.69

6.2

5.8

11.71

11.72

mg/l

0.00

370

1824

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

666

3824

1.62

29.60

1.6

1.02

6.91

iu/ml

1.80

161

851

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1936

13678

1.34

29.17

1.8

1.7

1.62

1.51

5.57

1579

11775

(3006270) Folate [Moles/volume] in Blood

277

1229

2.09

28.46

1.3

1.2

306.17

337.05

nmol/l

1.57

189

1006

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

488

2609

1.74

28.42

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

625

3577

1.63

28.16

2.0

1.9

11.21

11.17

mg/l

0.04

585

3297

(3043410) Blood group antigens tested for on Red Blood Cells

115

336

3.16

28.13

2.1

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

649

3754

1.61

28.00

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

395

1993

1.84

27.95

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

311

1452

1.99

27.80

1.4

1.3

7.12

6.13

mmol/l

5.02

292

1332

(3042631) Mycobacterium sp identified in Specimen

443

2318

1.78

27.80

2.4

2.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

648

3761

1.61

27.57

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

642

3723

1.61

27.41

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

472

2526

1.74

27.40

1.4

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

277

1251

2.05

27.16

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

11.06

27.11

6.0

5.5

348.47

456.56

umol/l

1.67

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

893

5599

1.49

26.81

2.5

2.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

846

5261

1.50

26.44

1.1

77.08

211.39

titre

3.68

145

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

694

9596

0.65

25.94

2.0

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

403

2095

1.79

25.89

1.5

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

334

1641

1.89

25.73

1.6

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

599

3475

1.60

25.55

1.6

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

170

644

2.44

25.52

1.2

1.1

1.09

1.07

ratio

0.76

214

(3047189) Immunofixation for 24 hour Urine

170

644

2.44

25.52

1.7

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

329

1616

1.89

25.37

1.3

1.2

4.74

3.66

u/ml

0.52

152

720

(3003327) Ova and parasites identified in Stool by Light microscopy

647

3833

1.57

25.26

1.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

149

533

2.58

25.22

3.1

3.8

2888.36

2199.85

mg/l

0.12

104

357

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

315

1536

1.90

24.85

3.3

3.8

—

(3010838) Calcium [Moles/time] in 24 hour Urine

400

2104

1.77

24.71

2.0

1.7

4.55

5.05

mmol/24h

2.14

340

1826

(3016650) Hepatitis A virus Ab [Presence] in Serum

360

1839

1.82

24.53

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

269

3.26

24.51

5.8

5.6

—

(3000492) Spirometry study

1767

12625

1.32

24.42

1.6

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

510

2882

1.65

24.21

1.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

174

684

2.35

24.10

11.8

4.4

2183.53

7045.76

u/ml

0.31

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2236

16515

1.28

23.98

1.4

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

573

3364

1.58

23.28

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

284

1369

1.92

23.22

1.4

—

(3013762) Body weight Measured

9.56

22.94

1.3

1.2

—

(3051651) Icteric interference index of Serum or Plasma

186

769

2.24

22.93

4.8

3.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

305

1514

1.87

22.82

1.4

1.3

257.09

483.33

u/l

3.78

287

1434

(3004716) Salmonella sp identified in Stool by Organism specific culture

814

5178

1.47

22.73

1.3

—

(3045414) Leukocytes [Presence] in Urine

975

6415

1.42

22.71

2.1

1.8

—

(3017569) Oxygen content in Arterial blood

166

659

2.33

22.52

2.0

2.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

256

1205

1.97

22.46

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

644

3914

1.53

22.45

1.7

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

460

2584

1.65

22.38

1.5

1.4

—

(40768806) Pleura Pathology biopsy report

336

1731

1.80

22.31

1.6

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

131

469

2.58

22.20

1.1

4.56

15.00

u/ml

—

(3012441) Differential panel - Pleural fluid

333

1715

1.80

22.14

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

280

1369

1.90

21.97

3.8

2.6

—

(3002256) Pathology report gross observation

2583

19592

1.25

21.95

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1041

6973

1.39

21.87

1.2

125.30

130.93

iu/ml

0.17

365

2510

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

104

335

2.87

21.60

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

140

526

2.46

21.48

2.4

2.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

691

4308

1.49

21.36

1.4

—

(3035880) pH of Pleural fluid

200

877

2.11

21.33

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1310

9152

1.34

21.09

2.4

22.07

25.61

au/ml

0.42

624

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

414

6128

0.61

21.03

1.6

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

216

984

2.03

20.82

1.5

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

306

1566

1.81

20.81

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

469

2703

1.61

20.63

1.4

1.5

2167.30

2309.25

e6/l

0.04

381

2251

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.33

20.50

4.8

2.8

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

120

429

2.58

20.44

1.4

1.6

2.68

9.59

nmol/l

0.66

105

356

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

180

3.54

20.28

2.2

2.6

104.03

50.77

mg/l

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

467

2702

1.61

20.22

1.3

1.4

34.15

31.50

e6/l

0.06

353

2153

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

145

573

2.34

19.94

1.4

1.3

62.07

63.73

0.21

113

470

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

371

2033

1.69

19.89

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

186

816

2.11

19.85

1.2

99.28

89.35

u/l

0.51

161

703

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

182

792

2.13

19.83

1.2

28.78

23.93

u/l

0.49

158

670

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

416

2357

1.64

19.62

1.2

40.27

44.88

u/ml

0.18

234

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

137

534

2.37

19.45

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

175

756

2.14

19.44

2.3

2.9

36.93

37.35

0.08

444

(3023199) Leukocytes [#/volume] in Pleural fluid

364

2006

1.68

19.12

1.5

1562.65

2588.56

e6/l

2.46

247

1468

(3044290) Cell count panel - Cerebral spinal fluid

433

2496

1.61

19.06

1.3

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

224

1068

1.94

19.02

2.2

2.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

400

2264

1.64

18.96

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

365

2020

1.68

18.88

1.5

1.6

0.68

0.88

g/l

3.08

282

1498

(3039162) Centromere protein B Ab [Units/volume] in Serum

290

1505

1.78

18.87

1.2

42.19

58.94

u/ml

0.58

107

(3035947) Staphylolysin Ab [Units/volume] in Serum

159

672

2.19

18.68

1.2

1.1

3.25

4.11

iu/ml

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

348

1920

1.68

18.23

1.0

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

234

1154

1.88

17.98

1.1

97.08

95.28

0.44

221

1068

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

517

3153

1.52

17.81

1.3

557.71

575.50

mg/l

0.27

491

2988

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

104

372

2.58

17.76

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

272

1411

1.79

17.76

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

126

494

2.36

17.70

1.4

2.27

2.51

0.14

102

405

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

372

2105

1.64

17.69

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

161

3.49

17.67

4.5

5.2

59.15

39.80

ug/min

1.14

131

(44816559) Phosphatidylethanol [Mass/volume] in Blood

354

1981

1.66

17.58

1.3

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

121

468

2.39

17.53

1.0

1.1

105.18

97.70

1.92

109

363

(3023410) Appearance of Cerebral spinal fluid

228

1126

1.87

17.46

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

521

3201

1.51

17.35

1.3

4.64

5.52

u/ml

0.13

363

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

236

1183

1.85

17.25

1.6

1.4

13.89

12.79

u/l

1.94

227

1131

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

723

4741

1.42

17.20

1.1

1.90

7.43

u/ml

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

336

1872

1.66

16.99

1.3

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

240

1219

1.82

16.83

1.4

1.3

12.30

13.32

u/l

0.24

221

1131

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

516

3185

1.50

16.82

1.5

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

178

820

2.01

16.74

1.3

1.4

13.74

13.31

umol/l

0.32

172

767

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

555

3481

1.48

16.73

1.3

20.39

36.60

u/ml

1.40

217

(3028308) Erythrocytes [#/volume] in Pleural fluid

331

1849

1.66

16.58

1.5

43574.64

56080.32

e6/l

0.58

196

1115

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

181

843

1.99

16.52

1.5

1.6

9.64

6.91

u/l

1.21

138

672

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.71

16.47

5.2

3.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

521

3238

1.49

16.43

1.3

7.47

5.54

u/ml

0.31

549

(3044927) Protein electrophoresis panel - Urine

287

1549

1.72

16.36

1.2

—

(3045424) Erythrocytes [Presence] in Urine

412

2438

1.57

16.30

1.8

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1166

8315

1.31

16.21

1.3

60.39

56.74

au/ml

0.18

499

(3021387) Prolactin [Units/volume] in Serum or Plasma

379

2203

1.59

16.19

1.9

1.7

291.93

277.63

mu/l

0.41

343

2035

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

452

2738

1.53

16.11

1.2

1.3

4.11

3.78

mmol/l

5.84

422

2569

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

158

709

2.06

15.99

1.2

1.1

30.47

21.72

u/l

0.93

140

625

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

158

710

2.06

15.93

1.2

1.1

90.95

81.47

u/l

0.51

139

629

(1002224) Polysomnography panel

670

4397

1.42

15.89

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

205

1011

1.88

15.82

1.1

1.2

85.00

120.43

titre

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

134

567

2.18

15.78

1.3

1.2

6.27

6.10

mmol/l

0.62

125

536

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

168

775

2.00

15.77

1.6

1.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

205

1012

1.87

15.77

1.1

1.2

96.15

167.88

titre

1.96

184

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

194

945

1.90

15.55

1.2

1.3

2.15

2.22

mmol/l

0.37

179

871

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4520

37089

1.16

15.54

3.2

3.1

0.80

0.78

ug/l

0.38

3211

25282

(3000919) Neutrophils/100 leukocytes in Pleural fluid

111

438

2.34

15.44

1.5

1.3

19.78

21.36

0.24

388

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

426

2575

1.53

15.36

1.5

1.6

58.11

7.93

iu/l

0.72

113

786

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

155

704

2.03

15.21

1.8

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

235

1225

1.77

15.17

1.3

1.5

31.00

23.05

iu/ml

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

155

705

2.03

15.15

1.8

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

495

3107

1.48

14.91

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

481

3002

1.49

14.90

1.4

1.3

—

(4035726) Immunohistochemistry procedure

1803

13694

1.23

14.83

1.4

—

(3012898) Urea [Moles/volume] in Urine

114

3.72

14.67

1.3

1.4

149.47

179.94

mmol/l

0.90

100

(4062490) Immunoglobulin typing, IgG

242

1287

1.74

14.60

1.5

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

154

709

2.01

14.58

1.7

2.0

15.92

16.27

nmol/l

0.22

139

668

(4200892) Spirometry reversibility

1490

11107

1.25

14.52

1.5

1.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

232

2.82

14.52

1.4

7.35

10.44

0.52

110

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

826

5699

1.35

14.46

2.4

3.5

3691.75

1431.68

u/ml

0.32

686

4892

(43055442) Apixaban [Mass/volume] in Serum or Plasma

193

3.01

14.45

1.9

1.5

120.32

117.16

ug/l

0.07

157

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

244

2.76

14.32

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

333

1941

1.59

14.13

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

108

440

2.27

14.00

1.1

1714.44

1560.96

miu/ml

0.75

108

440

(3016018) Differential panel - Cerebral spinal fluid

238

1277

1.72

13.94

1.3

1.4

—

(3045788) Cell count panel - Pleural fluid

273

1526

1.66

13.74

1.5

—

(3014891) Appearance of Pleural fluid

199

2.92

13.72

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

111

462

2.22

13.68

2.4

3.1

28.65

24.24

mu/l

0.53

102

433

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

220

1162

1.75

13.63

1.5

1.8

4.73

3.73

mg/l

1.86

214

1095

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6109

51563

1.13

13.43

4.6

4.4

22.63

21.77

4.23

3123

26574

(3045142) Bone marrow Pathology biopsy report

291

1664

1.62

13.39

1.2

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

224

1198

1.73

13.30

1.4

1.6

—

(3023419) Bacteria identified in Sputum by Culture

398

2449

1.51

13.27

2.1

2.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

155

743

1.93

13.13

2.2

254.96

67.39

ug/min

0.85

157

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

5.06

13.12

13.4

8.5

167.45

384.16

e6/l

0.54

(40757373) Influenza virus identified in Isolate

257

2.62

13.00

1.8

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

111

473

2.17

12.94

1.6

1.8

112.22

122.95

umol/l

0.11

251

(3024263) Appearance of Synovial fluid

166

821

1.87

12.80

1.4

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

136

629

2.00

12.78

1.3

1.2

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

14.88

12.77

12.6

9.2

50.21

51.75

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

470

3022

1.44

12.56

1.2

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

12.67

12.53

1.4

1.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

432

2735

1.46

12.53

1.2

6.45

4.90

u/ml

0.13

227

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

437

2774

1.46

12.50

1.2

15.49

13.88

u/ml

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

235

1298

1.67

12.43

1.4

2.71

3.06

g/l

2.61

172

881

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

13.82

12.42

13.6

9.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

234

1297

1.67

12.22

1.4

0.43

0.44

g/l

0.15

171

886

(3027135) IgG subclass 1 [Mass/volume] in Serum

234

1299

1.67

12.15

1.4

6.84

7.02

g/l

0.22

169

884

(3021788) Differential panel - Synovial fluid

447

2868

1.44

12.10

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

296

1745

1.57

12.04

1.1

1.53

1.54

g/l

0.03

269

1574

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

141

684

1.90

11.59

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

141

684

1.90

11.59

1.3

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

163

829

1.82

11.55

10.0

11.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

169

872

1.79

11.43

1.6

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

823

5876

1.30

11.40

1.9

1.7

—

(3014271) Vancomycin [Susceptibility]

166

853

1.80

11.38

3.1

3.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

143

702

1.88

11.35

1.3

1.30

1.19

nmol/l

0.43

548

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

103

450

2.11

11.34

1.7

2.4

176.69

159.11

0.88

424

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

103

450

2.11

11.34

1.6

1.9

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

17.40

11.04

4.4

2.8

—

(3000285) Sodium [Moles/volume] in Blood

198

2.70

11.03

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

159

815

1.80

11.01

3.5

3.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

256

1493

1.59

10.96

1.2

8.23

7.59

mmol/l

2.00

201

1272

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

167

871

1.77

10.92

1.6

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

289

1735

1.54

10.90

3.6

3.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

366

2309

1.47

10.87

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

567

3863

1.36

10.87

1.6

13955.46

14331.24

e6/l

0.08

412

2834

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

641

1.90

10.85

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

816

5866

1.29

10.75

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

245

2.48

10.63

3.3

3.0

14.51

14.84

ml/dl

0.42

232

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

113

3.26

10.58

1.2

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

109

500

2.01

10.57

2.6

2.2

55.00

51.58

umol/l

0.45

418

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

191

1050

1.68

10.37

1.1

—

(3003129) Base excess in Capillary blood by calculation

387

2.15

10.36

1.3

1.8

0.27

0.90

mmol/l

0.78

371

(3009214) Lutropin [Units/volume] in Serum or Plasma

397

2568

1.43

10.36

1.3

1.4

9.92

10.23

u/l

0.19

309

2088

(3034092) Cytoplasmic Ig cells/100 cells in Blood

164

2.81

10.28

15.5

7.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

113

531

1.96

10.26

1.7

2.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

655

1.86

10.19

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

322

4288

0.69

10.04

1.7

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

158

837

1.74

9.84

1.9

1.8

3.17

2.53

u/field

0.38

127

552

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

122

601

1.87

9.66

2.0

2.1

101.32

95.57

0.92

114

565

(36660697) Celiac disease serology panel - Serum

1242

9490

1.22

9.61

1.2

—

(40761535) Cells panel - Urine sediment

1719

13540

1.18

9.58

4.2

3.4

—

(3014051) Protein [Presence] in Urine by Test strip

548

3792

1.34

9.54

2.9

2.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

520

3571

1.35

9.52

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.36

9.49

1.5

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

875

6450

1.26

9.44

2.1

1.9

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

204

1171

1.61

9.40

1.9

1.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

278

1713

1.50

9.36

3.4

7.76

9.89

nmol/l

0.27

271

1669

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

163

885

1.70

9.33

1.8

2.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

230

2.41

9.09

1.4

1.2

—

(40768443) Skin Pathology biopsy report

916

6819

1.25

9.08

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

289

1813

1.47

8.93

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

288

1812

1.47

8.78

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

140

742

1.74

8.76

1.1

2.60

6.81

nmol/l

1.03

158

(3009466) Valproate [Moles/volume] in Serum or Plasma

285

1791

1.47

8.74

4.4

4.6

355.24

354.57

umol/l

0.03

239

1499

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

377

2.06

8.73

1.3

1.2

35.13

19.52

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

288

1815

1.47

8.71

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

101

485

1.92

8.68

1.3

251.08

317.99

ug/l

0.20

273

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.52

8.65

1.2

1.3

0.07

0.08

g/l

0.36

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

160

886

1.67

8.55

1.1

293.02

288.07

mg/l

0.37

139

788

(3009871) Measles virus Ab [Titer] in Serum

368

2.06

8.53

1.8

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

512

3569

1.33

8.53

3.1

3.3

586.88

565.44

u/ml

0.03

456

3235

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

431

1.97

8.51

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

162

903

1.66

8.45

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

287

1821

1.46

8.40

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

350

2303

1.41

8.39

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

350

2303

1.41

8.39

1.6

—

(44786800) Granulocytes/100 leukocytes in Body fluid

222

2.37

8.37

1.2

1.3

26.14

25.12

0.08

177

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

164

920

1.65

8.35

1.3

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

129

678

1.76

8.34

2.4

2.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1528

12058

1.18

8.33

2.4

2.1

11.80

12.88

nmol/l

5.68

1313

10746

(3024522) Salmonella sp identified in Specimen by Organism specific culture

288

1835

1.45

8.25

1.4

—

(3044941) Cell count panel - Synovial fluid

361

2396

1.39

8.24

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

157

874

1.66

8.24

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

169

2.56

8.18

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

156

869

1.66

8.17

1.2

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

350

2.06

8.14

1.5

1.4

14.48

15.69

pmol/l

1.22

293

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2584

21234

1.14

8.14

10.0

7.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

247

1536

1.49

8.03

1.5

1.6

—

(3016330) Potassium [Moles/time] in 24 hour Urine

139

2.72

8.01

1.2

—

86.21

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

155

869

1.65

7.93

1.2

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

140

2.70

7.90

1.1

11.69

21.57

iu/ml

0.69

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

155

870

1.64

7.90

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

291

1878

1.43

7.82

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

458

1.89

7.79

2.9

2.8

29.07

28.52

umol/l

0.19

349

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

155

874

1.64

7.77

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

155

874

1.64

7.77

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

134

728

1.70

7.74

1.6

1.5

5.42

5.86

u/l

0.38

111

605

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

247

1551

1.47

7.67

1.7

1.5

26.95

29.45

0.57

165

948

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

103

2.95

7.50

1.3

2.1

0.67

1.14

mmol/l

0.94

(3038071) Oxygen [Partial pressure] in Mixed venous blood

282

2.13

7.45

13.4

7.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

196

1181

1.53

7.44

1.4

1.6

18.10

25.31

u/ml

0.88

256

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

100

508

1.82

7.30

1.3

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

100

509

1.81

7.26

1.3

3.07

3.48

mmol/l

0.74

471

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

164

2.47

7.16

1.0

1.6

—

13.87

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

121

654

1.71

7.16

1.1

10.90

10.32

iu/ml

0.07

144

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

327

2191

1.38

7.12

1.8

26.00

23.98

ug/l

0.17

321

2146

(3006922) Hepatitis E virus Ab [Presence] in Serum

144

816

1.63

7.12

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

388

1.93

7.10

1.5

1.2

—

(3001729) Color of Synovial fluid

127

2.68

7.10

1.5

1.7

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

238

1509

1.46

7.07

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

238

1509

1.46

7.07

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

255

1647

1.43

6.88

1.1

—

(3017704) Immunofixation for Urine

138

785

1.62

6.75

1.2

1.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

123

681

1.67

6.69

1.4

1.6

—

(3011412) CD3 cells [#/volume] in Blood

202

1256

1.49

6.66

2.2

2.4

1.13

1.08

e9/l

0.40

191

1144

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

169

1016

1.54

6.54

1.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

227

1450

1.45

6.53

1.6

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

155

915

1.56

6.51

1.3

1.24

1.41

promille

0.75

102

703

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.03

6.46

1.1

—

(21494434) Karyotype in Bone marrow

216

1370

1.46

6.45

1.1

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

253

1653

1.41

6.44

1.1

15.19

11.87

au/ml

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

3.80

6.38

2.4

1.4

140.50

82.56

ug/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

183

1127

1.50

6.34

1.9

1855.08

2257.28

u/l

0.12

397

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

157

938

1.54

6.27

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

374

1.87

6.20

1.6

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

207

1314

1.45

6.18

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

207

1314

1.45

6.18

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

207

1314

1.45

6.18

1.6

—

(4212803) Bone marrow aspirate examination

126

2.56

6.16

1.1

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.86

6.16

29.4

8.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.02

6.10

1.1

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

245

2.07

5.97

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

245

2.07

5.97

1.9

3.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

334

1.90

5.94

12.9

7.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

277

2.00

5.92

1.1

1.2

447.87

267.24

pmol/l

0.70

205

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

290

1.97

5.90

1.2

—

(3034426) Prothrombin time (PT)

362

1.86

5.85

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

223

1456

1.41

5.75

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

139

827

1.55

5.70

2.0

15.79

27.58

umol/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

282

1920

1.36

5.66

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

166

2.28

5.64

2.0

2.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

156

2.30

5.53

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

152

2.30

5.39

1.2

1.1

20.71

19.49

u/l

0.11

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

257

1.97

5.29

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

270

1.95

5.27

1.1

0.61

0.95

umol/24h

0.69

123

(3028679) Herpes simplex virus Ab [Presence] in Serum

506

1.68

5.23

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

172

2.20

5.22

2.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

143

2.32

5.20

1.1

1.3

84.53

106.71

ug/l

0.49

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

155

2.26

5.17

1.4

1.6

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

161

1011

1.47

5.16

1.3

137.78

513.21

titre

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

127

759

1.54

5.15

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

157

982

1.48

5.14

1.1

1.2

—

(3047181) Lactate [Moles/volume] in Blood

584

4420

1.22

5.13

5.1

5.7

1.45

1.31

mmol/l

2.18

520

3908

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

127

761

1.54

5.10

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

320

1.84

5.05

2.3

2.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

237

1601

1.37

5.05

1.3

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

141

868

1.50

5.00

1.7

3.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

291

2033

1.32

4.97

1.3

158.66

209.36

miu/ml

1.27

759

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

155

978

1.46

4.88

1.3

55.00

90.94

titre

0.94

(3037692) Legionella sp identified in Specimen by Organism specific culture

546

1.62

4.83

1.6

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

511

1.64

4.82

1.2

1.3

40.32

40.01

g/l

0.06

275

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

540

1.62

4.79

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

256

3108

0.75

4.73

1.4

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

438

0.36

4.72

1.1

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

191

1262

1.40

4.69

1.1

1.2

—

(3019174) dRVVT (LA screen)

2.62

4.67

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

110

2.43

4.66

1.3

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

278

3328

0.77

4.64

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

290

1.84

4.61

1.2

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

389

1.71

4.44

1.1

1.3

0.32

0.31

g/l

0.31

307

(3020491) Glucose [Moles/volume] in Blood

158

1021

1.43

4.42

1.8

1.9

7.74

7.08

mmol/l

1.44

702

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

154

2.15

4.42

1.1

1.2

9.94

284971.46

nmol/l

1.08

133

(44813793) Dust mix specific IgE antibody measurement

137

862

1.47

4.42

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

210

1.97

4.41

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

101

598

1.56

4.34

1.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

114

2.34

4.34

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

126

2.27

4.31

1.8

1.9

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.63

4.29

2.7

4.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

233

1.90

4.21

1.1

0.34

1.05

u/ml

0.92

111

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

314

1.76

4.16

1.2

1.1

86.40

85.90

0.04

164

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

533

1.57

4.12

1.3

34.29

63.86

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

356

1.71

4.12

1.1

1.3

111.98

111.57

0.05

317

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

284

2036

1.29

4.09

1.5

63.81

59.10

1.33

191

1277

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

743

0.54

4.05

1.3

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

140

902

1.43

4.03

1.3

1.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

186

1.98

3.99

1.3

1.4

76.90

70.71

0.61

148

(3034891) Synovial lining cells/100 cells in Synovial fluid

123

775

1.46

3.98

1.6

1.5

5.38

4.14

0.27

162

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

107

656

1.50

3.96

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

137

882

1.43

3.96

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

597

1.53

3.96

4.9

6.2

—

(3029075) Extractable nuclear Ab panel - Serum

326

1.72

3.95

1.1

1.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

483

1.58

3.89

1.5

1.6

39159.92

21277.90

u/ml

0.18

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

394

2956

1.23

3.87

2.0

1.8

181.51

202.82

pmol/l

5.73

367

2789

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1477

15015

0.90

3.83

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

408

0.41

3.83

1.1

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

183

1.96

3.81

2.2

1.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

407

0.41

3.81

1.1

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

406

0.41

3.79

1.1

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

405

0.41

3.77

1.1

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

114

717

1.47

3.75

1.1

—

(3036180) Methadone [Presence] in Urine

277

1.76

3.73

1.2

2.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.92

3.72

1.7

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

332

1.69

3.72

1.3

27.30

48.72

g/l

0.61

254

(3047185) IgG [Mass/volume] in Urine

4.60

3.70

1.0

—

42.58

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

203

1412

1.33

3.69

1.2

1.3

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

148

2.05

3.65

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

334

1.68

3.65

3.2

2.4

8.18

7.33

mmol/l

0.82

201

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

134

874

1.41

3.64

3.7

4.6

107.18

164.11

u/ml

0.37

255

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

537

1.53

3.59

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

322

1.69

3.58

1.1

87.07

86.17

0.08

164

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

324

1.68

3.51

1.2

111.21

101.37

1.05

297

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.30

3.51

1.0

1.1

8.13

11.35

u/l

0.51

(3019225) pH of Specimen

1939

16435

1.10

3.47

6.2

3.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

318

1.68

3.47

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.28

3.43

1.3

1.6

0.66

0.71

umol/l

0.18

(3050794) Legionella sp Ab [Presence] in Serum

121

2.13

3.42

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

121

2.13

3.42

1.1

1.2

37.20

22.64

—

(37021550) Renin [Units/volume] in Plasma --upright

244

1.77

3.41

1.1

1.2

117.52

52.82

mu/l

0.87

179

(43055514) Macroprolactin [Presence] in Serum or Plasma

134

2.06

3.38

1.1

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

356

1.63

3.37

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

346

0.40

3.37

1.1

1.5

—

(40768441) Liver Pathology biopsy report

148

999

1.37

3.32

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

135

2.05

3.32

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

123

805

1.41

3.32

1.1

325.88

317.22

mg/l

0.15

706

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

261

1.73

3.27

1.4

1.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.89

3.22

1.1

—

mmol/l

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

215

1.80

3.21

1.3

68.40

521.44

ng/l

0.68

150

(3032057) Clostridioides difficile [Presence] in Stool

305

1.66

3.19

2.0

1.7

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

125

2.06

3.17

2.1

2.3

69.05

58.28

1.06

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.32

3.17

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

336

0.41

3.17

1.1

1.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

292

1.67

3.15

1.1

1.2

0.88

38.36

mg/l

0.99

229

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

539

1.49

3.15

1.1

243.23

911.52

ng/l

1.22

131

(3050129) First trimester maternal screen panel - Serum or Plasma

497

0.52

3.13

1.5

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

5.26

3.11

1.1

—

(3005033) Fetal Nuchal fold Thickness US

333

0.41

3.10

1.1

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

379

1.58

3.10

1.5

1.4

14.93

13.33

g/l

0.89

281

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

220

1589

1.28

3.10

1.1

0.80

1.45

u/ml

1.15

103

801

(3034274) Bile acid [Moles/volume] in Serum --fasting

609

1.45

3.09

1.2

1.6

9.14

13.49

umol/l

0.90

430

(3041918) Cholesterol [Moles/volume] in Pleural fluid

315

1.64

3.08

1.1

1.2

1.79

1.66

mmol/l

0.25

185

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

152

1.94

3.08

1.5

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

152

1.94

3.08

3.6

3.2

1.11

1.15

mg/l

0.09

109

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

142

966

1.36

3.07

1.3

1.4

30.33

31.64

u/l

0.18

105

795

(3020393) Adenovirus Ag [Presence] in Stool

121

2.06

3.04

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

126

846

1.37

2.97

1.1

47.47

46.70

mg/l

0.06

100

708

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

326

1.61

2.96

1.4

1.2

—

(3027874) Urate [Moles/volume] in Urine

2.66

2.95

1.0

1.1

1.86

1.54

mmol/l

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

9.21

2.83

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.69

2.82

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

591

1.43

2.81

1.5

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

178

1.81

2.77

3.1

2.4

0.51

0.53

u/field

0.04

178

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

578

1.44

2.76

1.1

1.09

1.11

u/l

0.13

284

(3008536) Aspergillus sp Ab [Presence] in Serum

305

1.60

2.71

1.5

2.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

4.33

2.70

1.0

1.1

—

(4034850) Laboratory test

460

4917

0.86

2.70

17.7

10.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

438

1.49

2.68

1.3

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

2.15

2.67

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

201

1.74

2.66

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

156

1105

1.30

2.61

1.2

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

138

965

1.32

2.55

4.2

3.7

147.29

157.45

nmol/l

0.10

138

949

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.24

2.53

1.3

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.53

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

124

1.93

2.52

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

216

1601

1.24

2.52

1.5

1.4

82756.81

143225.18

e6/l

0.92

170

1101

(3024869) Neuronal Ab [Presence] in Serum

284

1.59

2.46

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

113

777

1.34

2.37

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.43

2.36

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

131

921

1.31

2.36

2.3

1.5

88.80

88.85

umol/l

0.00

131

921

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

209

1.67

2.35

1.2

99.63

80.09

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.07

2.35

1.1

1.15

0.98

u/field

0.51

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1208

0.74

2.35

1.4

1.3

150.15

178.75

pmol/l

1.67

1208

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

116

803

1.33

2.33

1.8

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

217

1.66

2.32

1.2

1.3

48.89

49.69

—

106

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

116

805

1.33

2.30

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

121

845

1.32

2.29

1.9

1.7

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

183

1.71

2.28

1.8

1.5

27.65

67.26

pmol/l

2.44

146

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

211

1.66

2.28

1.2

78.13

75.99

—

(3004616) Nuclear Ab [Presence] in Serum

229

1731

1.22

2.26

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

116

807

1.32

2.26

1.3

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.17

2.26

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

350

1.50

2.25

1.2

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.57

2.25

1.1

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

651

1.36

2.22

1.1

1.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

104

1.95

2.22

1.3

1.2

0.75

1.17

ml/s/173m2

1.31

(3013166) Neutrophils/100 leukocytes in Synovial fluid

535

1.40

2.20

1.5

1.3

66.59

54.96

2.29

457

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

338

1.50

2.18

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

116

815

1.31

2.13

1.3

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.23

2.11

1.1

1.2

1374.60

2572.20

ng/l

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

202

1.64

2.10

1.1

1.3

1012.14

78.81

u/l

0.45

146

(3011288) Drugs identified in Urine by Screen method

174

1291

1.24

2.08

2.4

3.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

487

1.40

2.07

2.4

1.9

48.27

60.08

ug/l

1.13

472

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.19

2.04

1.2

1.4

1.00

1.03

u/field

—

(3036071) Salmonella sp Ab [Titer] in Serum

336

1.48

2.04

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

318

2509

1.17

2.00

1.4

1.3

29.42

34.15

iu/l

1.72

253

2156

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

205

1.62

2.00

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

345

1.47

2.00

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

234

1.57

1.99

1.1

1.2

0.88

1.34

mmol/l

0.40

152

(3008401) Mugwort IgE Ab [Units/volume] in Serum

183

1375

1.23

1.97

1.1

0.63

1.11

u/ml

0.75

565

(3026480) Teichoate Ab [Titer] in Serum

136

1.76

1.96

1.0

1.1

—

2.00

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

355

1.45

1.94

1.2

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.60

1.93

3.0

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

188

1421

1.22

1.92

1.1

2.46

3.53

u/ml

0.64

671

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

326

1.47

1.91

1.2

1.1

—

(40768793) Breast Pathology biopsy report

356

2848

1.15

1.89

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

224

1.56

1.85

7.6

6.7

—

(3017732) Neutrophils [#/volume] in Blood

1151

9834

1.08

1.83

3.6

2.9

5.41

5.20

e9/l

0.19

836

7594

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

643

1.32

1.81

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

643

1.32

1.81

1.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

338

1.44

1.80

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

147

1.69

1.80

1.2

1.1

—

(3034614) HLA Ag [Interpretation]

3.07

1.79

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

731

7375

0.91

1.79

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

120

871

1.27

1.78

1.3

1.41

1.48

u/ml

0.04

524

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

653

1.31

1.78

1.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

270

2129

1.17

1.76

2.1

29.62

27.01

mg/l

0.24

574

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

220

1.55

1.76

1.1

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.99

1.75

1.3

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

402

1.40

1.75

1.4

15.87

23.43

2.04

337

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.93

1.71

1.1

1.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

211

1634

1.19

1.71

2.7

3.6

56.94

56.95

0.00

163

1371

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

222

1.53

1.70

1.7

1.1

—

(3028433) Virus identified in Specimen by Culture

475

1.36

1.69

1.1

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.25

1.69

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

231

1.51

1.65

1.1

1.3

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.94

1.64

1.2

2.7

1.43

31.26

pmol/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

159

1.62

1.9

1.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

704

1.28

1.61

1.3

1.53

1.54

g/l

0.13

704

(40768795) Lymph node Pathology biopsy report

198

1535

1.19

1.60

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

180

1384

1.20

1.60

1.1

3.31

3.70

u/ml

0.10

532

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

347

0.61

1.59

1.7

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

535

0.69

1.59

1.4

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

175

1.58

1.57

3.6

3.3

40.17

41.91

umol/l

0.14

143

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.89

1.54

1.2

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

492

4087

1.11

1.50

1.8

1.7

40.69

43.90

nmol/l

2.26

465

3955

(3045683) HLA typing for celiac disease panel - Blood or Tissue

567

1.30

1.48

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.44

1.47

1.3

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

146

1111

1.21

1.47

1.0

40.77

44.33

ng/l

0.45

111

733

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

145

1103

1.21

1.47

1.0

308.16

343.91

ng/l

0.87

112

738

(3006462) Nitrate [Presence] in Urine

104

764

1.25

1.46

4.0

3.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

136

1030

1.22

1.44

2.6

2.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

150

1.60

1.44

2.5

1.7

8.81

7.43

mmol/l

1.08

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.05

1.43

1.2

1.1

1.00

0.86

u/field

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.05

1.43

1.4

0.40

u/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

145

1107

1.21

1.42

1.0

745.96

717.00

ng/l

0.28

103

713

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.48

1.42

1.3

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.87

1.40

1.3

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

460

1.32

1.39

1.1

1.0

0.64

0.54

u/ml

0.23

141

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

167

0.50

1.39

1.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.63

1.36

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

446

1.32

1.36

1.1

1.0

0.66

0.52

u/ml

0.25

(3030313) Adrenal Ab [Titer] in Serum

2.18

1.35

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

124

1.63

1.34

1.1

1.70

1.77

umol/24h

0.12

124

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

205

1.48

1.34

1.0

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

1.34

0.0

1.0

—

2.80

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

431

1.32

1.34

3.6

3.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

274

1.41

1.34

1.4

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

1.73

1.34

1.9

2.4

13.67

21.67

0.82

(3033799) Differential panel - Peritoneal fluid

456

1.31

1.32

2.0

1.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

154

1.55

1.31

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.74

1.30

1.0

—

(3008898) HLA-B27 [Presence]

390

3234

1.11

1.28

1.1

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

381

0.68

1.27

1.3

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

105

1.67

1.26

1.1

1.4

0.13

nmol/l

0.05

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

333

1.36

1.25

1.8

1.5

0.37

0.40

ug/l

0.15

212

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

708

6045

1.08

1.24

3.2

3.8

58.13

71.20

u/ml

0.62

675

5815

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.87

1.24

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

164

1.52

1.24

1.1

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.99

1.23

1.3

1.6

1.21

1.41

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.99

1.23

1.3

1.6

0.60

2.03

mg/l

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.70

1.22

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

372

3088

1.11

1.21

1.1

2.20

9.80

u/ml

5.29

290

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.90

1.21

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

287

0.64

1.18

1.7

1.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

530

1.27

1.18

2.4

2.0

25.86

410.76

ug/l

1.24

502

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

395

0.70

1.16

2.3

143.80

148.50

nmol/l

0.09

344

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

290

1.37

1.16

1.2

1.1

—

(4281824) Cell count and differential, peritoneal fluid

180

1431

1.16

1.2

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.05

1.14

1.4

802.45

534.28

nmol/l

—

(3046861) Legionella sp Ag [Presence] in Urine

1.67

1.14

1.0

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

112

858

1.20

1.12

2.7

2.5

541.80

492.68

e6/l

0.36

733

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

1.62

1.11

1.2

1.1

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

2.42

1.10

1.0

1.8

—

2184.60

umol/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

139

1.52

1.10

1.7

2.1

13.90

17.31

umol/l

1.06

139

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

163

1.47

1.06

1.3

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

407

0.72

1.04

1.1

1.3

29.25

35.81

0.41

278

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

244

2002

1.12

1.02

2.2

2.6

845.81

1405.92

u/ml

0.24

234

1982

(3017315) Amylase [Enzymatic activity/volume] in Urine

103

794

1.19

1.00

1.1

1.2

230.89

342.68

u/l

0.99

744

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

122

0.53

0.99

1.0

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

121

0.53

0.99

3.6

2.7

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.88

0.99

1.1

1.0

228.50

364.19

u/l

—

(3017509) Phencyclidine [Presence] in Urine

1.75

0.97

1.2

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

161

0.57

0.97

2.2

2.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

397

3965

0.92

0.91

1.9

1.6

4.30

3.89

mg/l

0.28

331

2868

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

511

0.77

0.91

1.4

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.70

0.89

1.4

1.2

294.75

348.42

umol/24h

0.60

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

118

0.55

0.88

1.0

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

120

0.54

0.88

7.1

5.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

133

1406

0.87

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

371

0.74

0.86

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.55

0.85

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

156

1.42

0.85

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

134

1413

0.87

0.85

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.57

0.84

1.1

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

196

1.36

0.83

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

126

1.46

0.83

1.1

—

(40765096) Chromosome analysis panel by Banding

490

1.22

0.83

1.2

1.1

—

(46236302) HLA-C [Type] by High resolution typing

1.75

0.83

1.0

—

(40760409) HLA-A [Type] by High resolution

1.75

0.83

1.0

—

(40760410) HLA-B [Type] by High resolution

1.75

0.83

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

261

0.70

0.80

1.5

1.4

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.74

0.80

1.2

1.0

0.01

0.11

u/ml

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

251

2099

1.10

0.80

3.0

3.7

25.77

46.89

u/ml

3.54

242

2035

(3015076) Soybean IgE Ab [Units/volume] in Serum

386

0.76

0.79

1.1

1.0

0.29

1.25

u/ml

0.62

(3020717) Zinc [Moles/volume] in Serum or Plasma

519

1.21

0.78

1.2

1.3

21.51

26.07

umol/l

0.64

491

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

600

0.81

0.78

1.1

8.42

6.51

u/ml

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.62

0.77

1.6

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.57

0.75

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.52

0.75

1.8

1.5

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.52

0.75

1.3

59.80

1445.66

u/l

0.87

(3018291) Platelet Ab [Presence] in Serum

2.09

0.74

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.84

0.73

1.3

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

274

1.28

0.73

1.1

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.62

0.73

1.7

1.5

—

(40762814) Titanium [Mass/volume] in Blood

360

0.77

0.73

2.2

2.3

3.76

3.47

ug/l

—

127

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

365

1.24

0.72

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

365

1.24

0.72

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

365

1.24

0.72

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

365

1.24

0.72

1.1

—

(3020650) Glucose [Presence] in Urine

365

1.24

0.72

1.6

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

104

831

1.15

0.72

2.7

2.6

0.23

0.24

e9/l

0.37

732

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

1.55

0.72

1.2

1.3

0.50

1.43

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

131

1.41

0.70

1.1

—

(3024316) Viscosity of Plasma

1.58

0.70

1.4

2.4

1.68

1.70

mpas

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

188

1564

1.11

0.69

1.9

2.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

187

1.33

0.69

1.0

1.3

6.06

6.76

mmol/l

0.32

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.70

0.69

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

148

1.37

0.67

1.5

1.7

49.50

46.32

umol/l

0.13

148

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.61

0.64

1.2

1.0

0.02

0.24

u/ml

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.57

0.64

1.0

1.4

3.63

13.11

nmol/l

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.70

0.63

1.0

2.00

2.78

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.59

0.61

1.1

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.59

0.61

10.7

7.3

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.59

0.61

1.0

5.68

5.22

mmol/l

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.59

0.61

1.1

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

127

0.65

0.60

1.1

—

(3025130) Human papilloma virus identified in Specimen

124

1019

1.12

0.60

1.8

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

375

1.20

0.59

1.4

1.6

9.55

9.02

ug/l

0.40

375

(3013293) Extractable nuclear Ab [Presence] in Serum

201

1.28

0.58

1.5

1.6

—

(3002619) Bacteria identified in Specimen by Culture

317

1.22

0.58

1.2

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

529

1.17

0.58

1.9

12222.61

3861.26

e6/l

0.34

369

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.73

0.58

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

105

1.40

0.58

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

195

1.27

0.55

1.4

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

143

1193

1.10

0.54

1.2

75.17

77.06

u/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

143

1195

1.10

0.53

1.2

87.88

43.58

u/ml

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

107

1.38

0.53

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.49

0.53

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

146

1222

1.10

0.53

1.2

44.98

48.01

u/ml

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

466

1.17

0.52

1.7

12055.35

11375.93

e6/l

0.03

265

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

230

1.24

0.52

1.5

1.9

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.40

0.51

1.2

1.5

21.43

10.97

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

528

1.15

0.50

14.0

12.2

0.62

0.63

mmol/l

0.14

486

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

274

1.21

0.48

1.6

1.2

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

1.53

0.48

1.0

1.5

294.86

370.00

umol/l

—

(40763590) HLA-DQ beta [Type]

1.53

0.48

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

150

1.29

0.47

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

633

0.87

0.47

1.3

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

600

5299

1.04

0.47

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

118

1.33

0.46

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

110

1.34

0.46

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.46

1.3

1.1

—

(3013862) HLA-DP [Type]

1.43

0.46

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

193

1.24

0.45

1.2

2.8

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.40

0.44

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.37

0.44

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.63

0.42

2.2

2.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

321

0.83

0.41

1.8

1.9

2.12

6.94

ug/l

1.37

195

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

877

0.90

0.41

1.0

0.04

0.43

u/ml

1.40

249

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.07

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

101

1020

0.91

0.40

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.40

0.0

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

134

1138

1.08

0.39

1.2

13.33

6.48

u/ml

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.67

0.39

1.0

1.4

—

15621.25

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2179

20415

0.98

0.39

6.3

4.5

32.64

32.50

0.23

1517

13495

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.31

0.37

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

115

1.28

0.36

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

135

0.75

0.36

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

632

1.11

0.36

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

106

1059

0.92

0.35

1.1

1.0

3.65

3.03

u/ml

0.16

468

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.38

0.34

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

324

0.85

0.34

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

210

1827

1.06

0.34

2.0

1.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

100

1.29

0.33

1.6

2.8

—

(40763791) Oxygen content in Venous blood by calculation

1.31

0.33

7.0

6.0

12.72

11.32

ml/dl

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

661

5905

1.03

0.32

1.6

1.7

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

176

1.20

0.32

7.7

7.6

0.39

0.42

umol/l

0.09

159

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.35

0.32

1.3

1.2

1.30

1.36

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

234

2264

0.95

0.31

1.4

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

127

1.23

0.30

1.2

2.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

259

2278

1.05

0.29

1.9

1.8

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

189

0.83

0.28

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

414

1.11

0.28

1.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.25

0.27

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.23

0.27

1.3

1.0

8.62

8.36

mmol/l

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.27

0.26

1.2

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

158

0.82

0.26

1.1

61.30

67.97

u/ml

0.14

151

(3023511) Choriogonadotropin [Units/volume] in Urine

434

1.10

0.26

1.3

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.67

0.26

1.2

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

603

0.92

0.25

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

280

2480

1.04

0.25

1.5

1.4

163.85

177.32

pmol/l

0.19

267

2429

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.26

0.25

2.0

2.3

—

(3009677) Dengue virus Ab [Presence] in Serum

1.28

0.23

1.4

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.75

0.22

1.6

1.4

—

(3018572) Chloride [Moles/volume] in Blood

336

3190

0.97

0.22

6.2

6.5

104.57

105.22

mmol/l

1.52

305

2855

(3039000) Anion gap in Blood

336

3189

0.97

0.22

6.2

6.5

11.35

11.12

mmol/l

0.57

305

2854

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.21

0.0

1.3

—

(3008717) Parietal cell Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

757.00

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.21

0.0

1.1

—

19.70

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.21

0.0

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

241

0.88

0.21

1.0

11.88

10.06

u/ml

—

117

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

220

1.13

0.21

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

260

0.88

0.20

1.5

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

108

1.19

0.19

1.2

1.5

46.14

40.07

—

(3000060) B lymphocytes [#/volume] in Blood

288

0.89

0.19

1.6

2.1

8508.67

870.14

e6/l

0.42

148

(3010726) Horse dander IgE Ab [Units/volume] in Serum

129

1244

0.95

0.19

1.1

0.60

0.98

u/ml

0.76

592

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.19

0.18

1.1

1.5

—

(3022475) Manganese [Moles/volume] in Blood

1.23

0.17

1.0

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

103

902

1.05

0.17

1.4

0.23

0.21

nmol/l

0.15

633

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.15

0.17

1.1

341.57

286.06

nmol/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.13

0.17

1.0

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

665

0.94

0.17

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.75

0.17

1.0

1.2

—

1.52

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

136

1.15

0.17

7.4

5.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

330

1.09

0.17

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

145

1.14

0.16

1.4

1.9

—

(40758292) HTLV I+II Ab panel - Serum

207

1.11

0.16

1.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

207

1.11

0.16

4.8

3.2

57.86

142.52

ng/l

—

(40758358) Immune stain study

0.79

0.15

1.0

—

(40768800) Prostate Pathology biopsy report

459

4308

0.98

0.15

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

229

2049

1.03

0.15

1.8

2.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

666

1.05

0.14

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

328

0.93

0.13

1.8

8.40

8.94

mg/l

0.21

257

(3027008) Opiates [Presence] in Urine

230

2064

1.03

0.13

1.8

2.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

317

1.07

0.13

2.1

3.0

7.77

7.14

mg/l

0.18

255

(3025577) Chromium [Mass/volume] in Blood

134

1194

1.03

0.12

1.9

2.0

2.21

2.34

ug/l

0.13

107

1001

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

496

0.95

0.12

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

158

1.11

0.11

1.1

—

(3016879) Cocaine [Presence] in Urine

213

1917

1.02

0.11

1.8

2.2

—

(3001556) Androgen free Index in Serum or Plasma

1.12

0.10

1.2

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

124

0.89

0.09

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.13

0.09

1.0

—

(3027944) Amphetamines [Presence] in Urine

223

2016

1.02

0.08

1.7

2.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

179

1.08

0.08

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

179

1.08

0.08

1.1

1.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

396

1.05

0.08

1.9

1.6

—

270.20

iu/ml

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.14

0.08

1.1

1.9

—

(3026470) Cobalt [Mass/volume] in Blood

137

1234

1.02

0.07

1.8

1.9

3.54

3.82

ug/l

0.13

121

1134

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.08

0.07

6.4

9.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

135

1.09

0.07

1.1

—

(3028300) Cannabinoids [Presence] in Urine

228

2068

1.01

0.06

1.9

2.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

109

1.10

0.06

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

104

978

0.98

0.06

1.1

1.0

1.68

3.24

u/ml

0.98

363

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

272

1.05

0.06

1.0

1.1

—

(3048879) Bone marrow aspiration report

520

0.97

0.04

1.4

1.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.09

0.04

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

430

1.03

0.04

4.6

6.0

68.37

70.85

0.25

348

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

267

0.97

0.03

1.3

1.6

3.09

2.22

ug/l

0.55

144

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

389

3570

1.00

0.01

1.5

1.7

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

356

0.98

0.01

1.2

1.3

113.96

135.29

nmol/l

0.58

257

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

252

1.02

0.00

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

179

1.03

0.00

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

282

1.01

0.00

1.1

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.97

0.00

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

102

0.99

0.00

1.3

1.2

—

(3015183) Erythrocyte sedimentation rate

468

1.00

0.00

1.2

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

111

0.99

0.00

5.7

4.5

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3049233) Organic acids panel - Urine

0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.98

0.00

1.1

1.4

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3020132) Chylomicrons [Presence] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.86

-0.00

1.7

1.5

1.39

1.46

umol/l

—

(3042517) Benzodiazepines panel - Urine

0.98

-0.00

4.6

3.4

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.6

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.2

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPERLIPNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_HYPERLIPNAS	1.165 [1.06, 1.28]	0.001
Birth year	0.995 [0.99, 1.0]	0.243

During the follow-up period (1.1.1998 — 31.12.2019), 10429 out of 45459 females with E4_HYPERLIPNAS died.

Males

Parameter	HR [95% CI]	p-value
E4_HYPERLIPNAS	1.227 [1.11, 1.36]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 13142 out of 56206 males with E4_HYPERLIPNAS died.

Mortality risk

Mortality risk for people of age

years, who have E4_HYPERLIPNAS.

N-year risk	Females	Males
1	0.131%	0.161%
5	0.714%	1.224%
10	1.853%	3.317%
15	3.355%	6.239%
20	5.904%	10.686%

Relationships between endpoints

↥

Index endpoint: E4_HYPERLIPNAS – Hyperlipidaemia, other/unspecified

GWS hits: 28

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hyperlipidaemia, other/unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints